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ABSTRACT
Vibrio cholerae is typed serologically on the basis 
of somatic O-antigens. The serovar-specific antigens A, 
B, and C of V^. cholerae 01 are located in the 
polysaccharide (PS) moiety of the lipopolysaccharide 
(LPS) in the cell wall, but the exact structure and 
composition of these antigens are unknown. Presently, V. 
cholerae non-01 serovars are differentiated serologically 
by two independent typing systems. Each system utilizes 
whole cell vaccines which result in typing sera 
containing serovar-specific, anti-PS activity and 
non-specific, cross-reacting activities.
Serovar-specific anti-PS sera were produced in rabbits 
immunized with PS extracted from selected vaccine strains 
of cholerae 01 and non-01 conjugated with a protein 
carrier. In the passive hemagglutination assay versus 
LPS coated rabbit erythrocytes, the PS sera displayed 
titers comparable to those obtained with antisera from 
rabbits immunized with whole cell vaccines. In the slide 
agglutination test, anti-PS sera serologically 
distinguished isolates which had previously agglutinated 
in more than one typing serum. Thus, serovar-specific 
PS-associated antigens of cholerae are discernable 
serologically, in v i tro, and excellent immunogens when 
conjugated to a protein carrier, in vivo. In addition, 
hybridomas secreting monoclonal antibodies (MAbs)
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
directed against cholerae 01 were prepared by fusing 
spleen cells from mice immunized with whole cell vaccines 
and SP2/0-Agl4 myeloma cells. A library of nineteen MAbs 
was established; seven were specific for the A antigen, 
two for antigen B, and one for antigen C , as determined 
in an enzyme linked immunosorbent assay (ELISA) utilizing 
seven 01 and nine non-01 LPS preparations as the 
antigens. Each MAb displayed specificity when tested by 
slide agglutination and by ELISA against whole cell 
preparations of 36 01 and 52 non-01 cholerae serovars, 
20 heterologous Vibrio species, and 37 heterologous 
bacterial species. Three distinct reactivity patterns 
were exhibited among the anti-A clones. The reactivity 
and specificity of each MAb were further evaluated by the 
direct immunofluorescence assay and by immunoelectron 
microscopy on thin sectioned and whole cell mounts of V . 
cholerae 01. Finally, a mixture of MAbs increased the 
sensitivity of the reagent.
XI
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INTRODUCTION
Lipopolysaccharide (LPS), a macromolecular 
constituent of the outer leaflet of the Gram-negative 
cell wall, consists primarily of a linear polysaccharide 
linked to a core oligosaccharide. The polysaccharide 
portion contains the 0-, or somatic, antigenic 
determinants. This complex Is covalently bound to a 
llpld moiety, llpld A, which can evoke pathological and 
toxic responses In animals (Luderltz et al., 1971).
Vibrio cholerae can be serologically typed on the 
basis of flagellar (H) and 0-antlgens. Gardner and 
Venkatraman ( 1935) reported that motile strains of V . 
cholerae express a common, heat-labile, H-antlgen, but 
can be discriminated serologically Into six 0-antlgen 
groups. Presently, V_̂  cholerae are serologically 
classified Into at least seventy 0-groups, or serovars 
(serological varieties), based on the agglutination 
patterns and agglutlnln-absorptlon tests reported by 
Sakasakl et al. (1970), Shlmada and Sakasakl (1977), and 
Smith (1979). The cholera vibrios were assigned to 
serovar 01, which Is subdivided Into the Inaba, Ogawa, 
and Hlkojlma serological entitles predicated on the 
distribution of three somatic antigens (Burrows et al., 
1946). Inaba possesses antigens A and C, Ogawa A and B,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and Hlkojlma expresses all three antigens In the LPS.
The remaining seventy serovars, collectively referred to 
as non-01 vibrios, do not agglutinate In 01 antisera. 
Vibrio cholerae 01 are divided Into two blotypes, 
classical and El Tor, based on antibiotic resistances, 
phage sensitivity, Vogues-Proskauer reaction, haemolytlc 
activity, and ability to agglutinate chicken 
erythrocytes.
The earliest study In which the composition of the 
LPS of Vibrio cholerae was examined was with strain 569B 
(Inaba) by Jackson and Redmond (1971). LPS extracted 
from this strain contained glucose, mannose, heptose, 
small quantities of arablnose, and glucosamine. The 
heptose was thought to be either L-glycero-D-mannoheptose 
or Its enantlomer. The analysis accounted for about 70% 
of the weight of the LPS, and the authors speculated that 
the antlgenlcally Important sugar constituents had not 
been detected or Identified.
Subsequent studies (Jann et al., 1973) were done 
with Vj^ cholerae 569B and Vj_ cholerae NIH 41 (Ogawa).
The LPS of each strain was reported to be composed of 
heptose, glucose, fructose, glucosamine, and the unusual 
amino sugar, 2-amlno-2,6-dldeoxy-D-glucose, commonly 
known as D-qulnovosamlne. A second unique amino sugar, 
4-amlno-4,6-dldeoxy-D-mannose, known as D-perosamlne, was 
detected In a subsequent study by Redmond (1975). A
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linear (otl-2) linked polymer of this sugar, having a 
molecular weight of approximately 10,000 (about sixty 
perosamine units), was found to be the major constituent 
of the 0-antigenic side chain of cholerae 569B 
(Redmond, 1979). They speculated that the minor sugars, 
located at the reducing terminal, were probably part of 
the core region. Razuiddin (1980) fractionated the 
polysaccharide component of the LPS from three Inaba and 
two Ogawa Vm_ cholerae strains into the component core and 
side chain moieties, and reported that the side chain 
fractions contained high levels of mannose, rhamnose, 
glucosamine, D-perosamine, D-quinovosamine, and also some 
glucose and fructose. The proposed core fractions 
contained phosphorous, heptose, ethanolamine phosphate, 
and relatively large amounts of glucose and fructose.
The two amino sugars, D-quinovosamine and D-perosamine, 
represented the important constituents of the 0-side 
chain which had not been previously discerned.
To elucidate their serological relevance, the sugar 
constituents of the smooth strains, V_j_ cholerae 35A3 
(Inaba), cholerae NIH 41 (Ogawa), and cholerae 
P1418 (Ogawa), were compared to their respective rough 
mutants (Hisatsune and Rondo, 1980). Both smooth and 
rough LPS preparations contained glucose, fructose, 
heptose, and glucosamine. Quinovosamine and perosamine 
were present in the smooth LPS, but absent in rough LPS
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
preparations. Furthermore, passive haemolysis inhibition 
studies showed that concomitant with the depletion of 
quinovosamine and perosamine, the 0-specificity was 
abolished. The rough forms, regardless of the serotypes 
of their smooth parent strains, displayed a definite 
cross-reactivity.
In each strain studied, regardless of whether they 
were Inaba, Ogawa, or Hikojima, smooth or rough, 
classical or El Tor, 2-keto-3-deoxyoctonate (KDO), which 
bridges the core and 0-side chain regions in LPS 
preparations extracted from Gram negative bacteria 
(Luderitz et al., 1979), was not detected in chole rae 
(Jackson and Redmond, 1971; Jann et al., 1973; Hisatsune 
et al., 1977; Hisatsune and Kondo, 1980; Razuiddin, 1980; 
Kabir, 1982), whereas fructose was detected in each V . 
cholerae isolate examined. As a result, it was suggested 
that fructose, as a fructofuranoside (Redmond et al., 
1973), may replace 2-keto-3-deoxyoctonate in the LPS core 
of cholerae (Jann et al., 1973). Recently, Brade 
(1985) challenged this hypothesis when he reported 
detecting 2-keto-3-deoxyoctonate-5-phosphate in acid 
hydrolysis fractions of LPS extracted from cholerae 
95R (a rough mutant of Ogawa 162) and cholerae 569B.
In support of the latter, Sciortino et al. (1985) 
produced a monoclonal antibody (MAb) which recognizes the 
KDO-containing inner core region of Salmonella minnesota
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Re595, and reported that this MAb reacts with LPS 
extracted from a rough strain of cholerae (416-ORa).
Although the chemical composition of cholerae 01 
LPS has been intensively studied, the precise composition 
and structure of antigens A, B, and C have not been 
defined. Kenne et al. (1979) proposed that the A antigen 
is composed of the (pfl“2) linked homopolymer of 
perosamine residues (Redmond, 1979) which are N-acylated 
with 3-deoxy-L-glycero-tetronic acid. The perosamine 
residues may be substituted at position C3 and the 
tetronic acid residues may be substituted at position C2; 
the nature of the substitutions could account for the 
serological differences observed between the Inaba,
Ogawa, and Hikojima serovars.
Structural differences between cholerae Inaba and 
Ogawa LPS have been reported. Hisatsune et al. (1977) 
discovered that there is an internal glucose linked 
through the 6-OH group in Inaba LPS, whereas in Ogawa 
LPS, the internal glucose is linked through the 4-OH. 
Redmond (1978) detected 4-amino-4-deoxy-L-arabinose in 
Ogawa LPS but not in Inaba LPS and suggested that this 
sugar may be the critical parameter which differentiates 
the two serovars, a finding substantiated by Kabir 
(1982). Hisatsune et al. (1980), however, were unable to 
detect this amino sugar in the three Ogawa strains they 
examined. Sen et al. (1979) found that, upon hydrolysis.
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Inaba lipopolysaccharide yielded a
D-glycero-L-manno-heptose and a D-glycero-L-gluco-heptose 
in the molar ratios of approximately 5:1, while Ogawa 
lipopolysaccharide contained L-glycero-D-gluco-heptose as 
the major heptose, and only small amounts of 
L-glycero~D-manno“heptose were detected (Majumder at al«, 
1983). It is important to note that the heptoses of each 
serovar are optical isomers of the other, and that for 
Inaba LPS the dominant sugar is the mannoheptose, whereas 
for Ogawa LPS the dominant sugar is the glucoheptose.
Several oligosaccharides have been isolated and 
characterized from both Inaba (Sen et al., 1980) and 
Ogawa (Majumder et al., 1983) LPS and, along with various 
monosaccharides, have been used in precipitin inhibition 
assays in attempts to detect the antigenically important 
sugars which may constitute the A, B, and C antigens 
(Guhathakurta , 1986). D-glucuronic acid effectively 
inhibited precipitation of Inaba and Ogawa LPS by the 
respective antibody. D-glucosamine inhibited LPS 
precipitation but not to the same level as D-glucuronic 
acid. D-glycero-L-mannoheptose showed 20% inhibition of 
Inaba LPS while L-glycero-D-glucoheptose exhibited 8% 
inhibition of Ogawa LPS. The oligosaccharides were more 
effective inhibitors, and required lower quantities than 
the corresponding constituent monosaccharides. 
Unfortunately, the anti-A activity in the antisera had
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
not been absorbed to yield serovar-specific reagents.
Recently, genes clusters encoding enzymes 
responsible for the biosynthesis of the O-antigens (oag 
regions) of cholerae 01 Inaba and Ogawa have been 
cloned into Escherichia coli K-12 (Manning et al., 1986). 
Analyses of these large regions revealed identical 
restriction endonuclease cleavage patterns, implying that 
only minor differences determine the Inaba or Ogawa 
serovars. Further studies of these clones will 
undoubtedly help to unravel the mystery which presently 
surrounds the structure and composition of antigens A, B, 
and C in V. cholerae 01.
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CHAPTER I Production of Vibrio cholerae 01 and
non-01 typing sera in rabbits immunized 
with polysaccharide-protein carrier 
conjugates.
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Two systems are currenlly used to serologically type Vibrio clwlerae 01 and non-01 isolales. Anil- 
serovar-serotype serum in the Smith system is produced in rabhits immunized with live whole-cell vaccines, 
and that in the Sakazaki system is produced in rabbits immunized with heat-killed vaccines. In neither 
system is the serovar-serotype specilk antigen clearly defined. During the course of a serological survey, 
ca. 10% o f more than 2.500 V. rholrrae isolates examined agglutinated in the optimal dilutions of two. three, 
or four different anti-serovar sera prepared by the methods o f Sakazaki. An occasional isolate agglutinated 
in both anti-Ol and non-01 sera. Lipopolysaccharide was extracted from eight of these possible multiple 
serovars. coaled onto rabbit erythrocytes, and retested in these same antisera by passive hemagglutination.
With one exception the lipopolysaccharide-rabbit erythrocytes were now agglutinated in a single antiserum. 
Antipolysaccharide sera were produced in rabbits imnjunized with the polysaccharide moiety extracted 
from eight non-01 and two 01 vaccine strains conjugated to bovine gamma globulin protein carrier. The 
antipolysaccharide sera showed passive hemagglutination titers versus lipopolysaccharide-rabbit erythro­
cytes comparable to those achieved in antisera from rabbits immunized with heat-killed whole-cell vaccines.
In the slide agglutination test antipolysaccharide sera serologically discriminated between two 01 isolates 
that were previously agglutinated in both anti-Ol and anti-non-Ol whole-cell sera. It is recommended that 
serological types or varieties of V. cholerae non-OI be based upon serologically recognizable differences in 
lipopolysaccharide-associated antigens as are antigens A. B. and C in the 01 group.
Presently, two systems are used to serologically discrimi­
nate Vibrio cholerae non-01 serotypes. Sakazaki et al. (8- 
10) extended the number o f serologically detectable V. 
cholerae O antigen groups from the 7 reported by Gardner 
and Venkatraman (2) to 60. The immunological procedures 
and serogroup numerical designations suggested by Gardner 
and Venkatraman were continded by Sakazaki. except that 
Sakazaki identifies O-antigen groups in V. cholerae non-Ol 
as serological varieties (serovars) rather than O groups. A 
second typing system, developed by Smith ( I I .  12). present­
ly recognizes 72 serotypes; and the numerical designations 
assigned to non-Ol serotypes in this system were arrived at 
independently. The lack o f correlation in serological nomen­
clature has caused considerable confusion when attempts 
are made for epidemiological reasons to translate a Sakazaki 
serovar into a Smith serotype or vice versa. Brenner et al. (I) 
attempted to correlate serovar and serotype designations in 
each system by testing the non-OI vaccine strains from each 
collection in the typing sera of the opposite collection. 
Unfortunately, only 20 o f the Sakazaki vaccine strains were 
found to be serologically identical to 20 in the Smith system, 
whereas 15 serovars and 13 serotypes, respectively, ap­
peared to be unique to each system. The remaining vaccine 
strains in each system were agglutinated by two or more 
antisera in the opposite system, which made consistent 
correlations difficult.
Two reasons for the apparent lack o f correlation between 
these serological nomenclatures originate with the dispari­
ties in the methods used by each investigator to prepare 
vaccines and immunization protocols. First, typing sera 
produced in rabbits immunized with live vaccines in the 
Smith system will potentially react with heat-labile antigens 
that antisera produced in rabbits immunized with heat-killed
• Corresponding author.
vaccines in the Sakazaki system will not. Second. Sakazaki 
uses a series o f injections of the killed vibrios, in contrast to 
a single immunization which Smith uses, thereby increasing 
the chances of the production of antibodies in response to 
minor antigens. At the moment it appears that typing sera in 
each system may detect a serovar-serotype-specific antigen 
(yet to be defined); but these sera also contain serological 
activity directed against additional non-serovar-serotype- 
specific antigens, which accounts for the cross-reactions 
reported by Brenner et al. (I). To reconcile the two systems, 
it is imperative that the serovar-serotype-specific antigen be 
defined.
The Kaulfmann-Whiie (4) scheme used to serologically 
group salmonellae is predicated on the serological detection 
o f polysaccharide (PS) associated O antigens in the smooth 
core of lipopolysaccharide (LPS) in the outer membrane 
envelope. Similarly, serovar-serotype-specific antigens A. 
B. and C in V. cholerae 01 have been located serologically 
in the PS portion of the smooth core in LPS (5. 6). Because 
o f these precedents and for the sake of uniformity, it makes 
sense to serologically group V. cholerae non-OI oiganisms 
based upon the detection of serovar-serotype-specific LPS 
associated 0-antigens.
It is the intent o f this communication to show that LPS 
associated antigens unique to V. cholerae non-01 vaccine 
strains are serologically detectable and that antisera specific 
for these LPS-associated antigens can be produced in rabbits 
immunized with PS-protein carrier conjugates.
MATERIALS AND METHODS
Vaccine strains. Table 1 lists the V. cholerae non-01 
strains used to prepare vaccines. The Sakazaki serovar and 
the Smith serotype designations are provided. V. cholerae el 
tor Inaba (La 5875) and V. cholerae Ogawa (CA 411) were 
the C l serovars used.
10
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
11
ADAMS AND SIEBELING ). Cu n . MicROkioL.
TABLE I V. rhnterar non-OI viccine slreint uwd to produce 
serolo(ical typing sera









Crab hemolymph G 23 19
Sewer. Lake Arthur, La. 0 42 999*
Human, Louisiana Q 2 17
Human, Louisiana X 57 999
Sewer, Lake C3iartes, La. Y X64 350
Sewer, Welsh. La. FF XI2 999
Human. Dacca. UU Unknown' 21
Bangladesh 
Water. Florida XX Unknown Unknown
* N. C Roberts (Department o f Health and Human Resources. 
Stale o f Louisiana).
* Vaccine strains were arbitrarily assigned an alphabetical Louisi­
ana State University (LSU) serovar designation (Siebeling et al., in 
press).
*■ Isolales serologically typed by T. Donovan (Public Health 
Laboratory. Preston Halt Hospital. Maidstone. Kent. England).
'  Isolates serologically typed by H. L. Smith. Jr. (Jefferson 
Medical College, Philadelphia. Pa.)
'  Not typable.
^Serovar-serotype unknown.
Typing sera. Antisera to V. rholerar 01 and non-Ol 
strains (Table 1) were produced in rabbits Immunized with 
live vaccines prepared by the methods of Smith (11). heat- 
killed vaccines prepared by the methods of Sakazaki et al. 
(9), and PS-prolein carrier conjugates prepared from detoxi­
fied LPS conjugated to bovine gamma globulin (BGG).
Preparation of PS BGG immunogen. LPS was extracted 
from 4 to 10 g o f acetone-dried cells prepared from each of 
the V. chohrat vaccine strains by the method of Weslphal 
and Jann (14). Each LPS preparation (1 mg/ml) was detoxi­
fied in 0.2.S N NaOH at 3TC for 4 h, followed by 1 h at %°C. 
Detoxified LPS was dialyzed against water overnight, and 
then the lipid was sedimented by centrifugation at lOS.flOO x 
g for 3 h. The supernatant fluid, PS O-antigen, was lyophi- 
lized To conjugale PS to BGG. 10 mg of PS was dissolved in 
2 ml of 0.15 M H j BOj-0.5 M NaCI, pH 8.6. Next. 7 mg of 
CNBr crystals was added to the PS. and the solution was 
stirred for 15 min while the pH was maintained at 8.6. 
Activated PS was added to 10 ml of a 0.1% solution of BGG 
(Sigma Chemical Co.. St. Louis. Mo.) in borate-sodium 
chloride buffer, and the coupling reaction was allowed to 
proceed, with stirring, overnight at 4°C. Tlie PS BGG conju­
gate was dialyzed against 0.067 M phosphate-buffered saline 
(PBS, pH 7.3) for 6 h and then against saline overnight. The 
PS BGG preparation was concentrated to 5 ml. and 2.5 ml 
(ca. 5 mg o f the conjugate) was emulsified in an equal volume 
o f Freund adjuvant (Difco, Laboratories, Detroit. Mich.).
- Rabbits were immunized by ii(jec(ing 0.5 ml o f the PS BGG 
adjuvant intramuscularly into each hindquarter and in 7 to 10 
sites subcutaneously along the spine and the nuchal region. 
The animals received a second immunization 30 days later o f 
2.5 ml of PS-BGG incorporated into incomplete adjuvant.
Serology. Antibody activity in each preparation o f anti-V. 
choterae serum was tested by both slide agglutination and 
passive hemagglutination (PH A). V. r Werne cells harvested 
in PBS or 0.3% formolized PBS from a 24 h slant were mixed 
with various dilutions o f each antiserum on a glass slide and 
examined over a 1-min peritx) for evidence of agglutination. 
The PHA test was used to test each 01 and non-01 
antiserum for anti-PS activity by the addition o f LPS- 
sensitized rabbit erythrtxytes (RRBC) to dilutions o f each 
antiserum. LPS was extracted from environmental and vac­
cine strains. Before RRBC were sensitized. LPS was treated 
with 0.02 N NaOH (1 mgfml) for 5 h at 37%; and then 
neutralized in 19 volumes of PBS. To a 5% suspension of 
RABC washed three times (it: PBS) was added an equal 
vollime o f alkaline-treated LPS (50 pg/ml). and the suspen­
sion was incubated for 2 h at 37’C. LPS-sensitized RRBC 
were washed three times in PBS and resuspended to 0.5% 
(vol/vol) in PBS. Serial dilutions o f heat-inactivated antiser­
um were made in PBS. and an equal volume o f LPS- 
sensitized RRBC was added to each tube. Agglutination 
patterns were examined after 90 min at 37°C, and titers were 
determined after overnight incubation at 4°C.
RESULTS
Over 8 3 year period, more than 2.500 environmental V. 
clwlerae isolates were examined serologically by slide agglu­
tination in antisera raised in rabbits immunized with heat- 
killed vaccines prepared from 46 different V. cholerae non- 
O l serovars (7). Three hundred of the environmental isolates 
were agglutinated in the optimal dilutions of two or more of 
the anti-serovar sera. Table 2 lists eight representative 
isolates recovered in Louisiana which agglutinated in two, 
three, and four different antisera. Two isolates. La 8584 and 
La 9214, agglutinated in optimal dilutions of anti-Ol sera 
(Inaba, 1:80) and in an optimal dilution of anti-non-Ol serum 
XX. This serological dilemma txcurred frequently, making it 
difficult to serologically discriminate between 01 and non- 
O l serogroups. Kaper et al. (3) delected the gene for cholera
TABLE 2. Examples o f V. cholerae isolates which agglutinate in two or more anti-serovar sera
Slide «otutinalion reaction* in scrum produced against lieat-kitled vaccine strains of:
Live V. rholerar Ot
suspensions of: G* 0 Q X V FF UU XX La 3875 CA4I1
Inaba Ogawa
La 85*4 + + - f+ + -f
La 6480 + + -t-
La 9214 + + -S + -I- +
La 9296 + + -F + + +
La 6169 + + + +
La 6195 + •(• ■F +
La 9313 + + + -f + +
La 9302 + + ■f+ ++
" + + , Agglutinilion in optimal dilutions o f antiserum within 1 min; +. agglutination in low dilutions of antiserum within I min. 
* See Table I for Sakazaki serovar and Smith serotype designations.
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TABLE )  Serolnpcal fxnmmalion o f LPS e>lncicd from V. 
chdtrae itotales for evidence o f existence of multiple serotypes
PHA liter vs LPS sensitized RRBC in serum produced 
npnlnsl Rent killed vscdnes of:LPSezttueted___
from isolai cs 
Kslcdnnd 
cooled onto ^  
RRBC
O t




U8S84 0 40.000 20
U6480 160 0
La 9214 0 40.000 20
La 9296 0 320 0 40,000
La 6169 0 0
La 6193 2,360 2,360
La 9313 0 320 0 10.000
La 9302 0 640 0 40.000
• See Table I .  footnotes h, c, end <f.
toxin in Lk 8S84 which made it Important to ascertain 
whether this isolate was 01 or non-Ol. A second group o f V. 
cholerae isolates. La 9296, La 9313, and La 9302, were 
agglutinated in optimal dilutions o f anii-XX but not in 01 
serum (Table 2). These three isolates were also agglutinated 
in optimal dilutions o f anti FF and in low dilutions of anti O 
and anti-X sera. Do these findings imply that 01 and non 01 
serovar-serotyjse-specific antigens are coexpressed in V. 
cholerae isolates, or are diflerent classes of 0-antigens being 
detected? I f  La 8.384 is an 01 serovar, then anti-XX serum is 
reacting with either group-specific 01 LPS associated anti­
gen A, B, or C or with a non LPS associated antigen.
Since serovar-specific 01 antigens A, B, and C are struc­
tural components o f LPS (S, 6), it would be logical to 
serologically group V. cholerae non-01 isolates through 
serologically unique LPS-associated antigens. To determine 
whether isolate La 8384 exhibits 01 antigens A, B, and C 
and non-01 antigen XX in LPS, this cell wall component was 
extracted from each of the eight environmental isolates, 
coated onto RRBC, and retested by PHA in the same 10 
antisera. Table 3 shows the PHA liters of antisera produced 
against heat-killed whole-cell vaccines and tested against
LPS-sensilized RRBC. Anti-XX serum did not react with La 
8384 LPS-coated RRBC, whereas anti Inaba serum pro­
duced a PHA titer of 40,000. This indicates that anti-XX 
serum, when tested by slide agglutination (Table 2) against 
isolate La 8384, reacted with a non-LPS-associated antigen. 
The implication is that La 8384 is a V. cholerae 01 serovar. 
La 9214 LPS-sensitized RRBC were also agglutinated in 
anti-Ol serum only.
Isolates La 9296. La 9313, and La 9302 appear to be V. 
cholerae non-01 serovar XX since LPS extracted from these 
organisms exhibited elevated PHA tilers in anti-XX serum, 
with no reaction in anti O or anti FF serum, but showed low- 
level activity in anti-X serum (Table 31 Isolate La 6169 does 
not appear to be serotype Q or Y but some yet to be 
identified serovar; however, the validity o f this interpreta­
tion should be questioned based upon the extremely low 
yield o f LPS extracted from this isolate. It is possible that 
RRBC were not optimally sensitized with La 6169 LPS, i f  at 
all. It appears that typing sera raised in rabbits immunized 
with heat-killed vaccines possess serovar-specific anti LPS 
activity i f  the serovar-specific antigen is defined as LPS; and 
some typing sera also possess high levels of antibody activity 
to a yet to be defined heat-stable, non-LPS antigen shared 
Btnong serogroups.
•When a V. cholerae isolate is agglutinated in two or more 
anti-serovar-sera, it is not expedient to extract LPS to 
ascertain by PHA the serological type or variely. Rather, 
serovar-specific (anti-LPS) typing sera are required. With 
this objective in mind, rabbits were immunized with PS- 
BGG cor\jugates to produce LPS-specific typing sera. PS- 
BGG conjugates were prepared from LPS extracted from the 
eight non-OI vaccine strains (Table 1) and V. cholerae C l 
(La 3875 and CA 411). Figure 1 compares the anti-LPS 
antibody responses in representative rabbits immunized with 
a live vaccine, a heat-killed whole-cell vaccine, or PS-BGG 
coiyugate prepared from V. cholerae 01 Inaba (La 3873) and 
Ogawa (CA 411). Fifty percent o f the rabbits immunized 
with live 01 or non 01 vaccines died by days 3 to 4 
postimmunization. Those that survived showed low levels of 
anti-PS (1:80) at the time of exsanguination on day 14. Smith 






60497 14 28, 35 42
PS-BCG PS-BCG
FIO. 1. Anti-LPS PHA titer* in antisera produced in rabbits immunized with three dilferent vaccine preparations o f V. rholerar O l. 
Antisera produced in rabbits immunized with live whole-cell vaccine, heat-killed whole-cell vaccine, and PS-BGG carrier conjugates were 
tested against homologous LPS coated onto RRBC.
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TABLE 4. Specificily o f «nii-PS wramt PHA lile n  o f anIi-PS sera lesled against homolagous and heterologous LPS prepared from V.
rkn lrrtif OJ and non-OI vaccine strains
PHA iHcr of antherum produced agahnl:
RRBC coaled wilh 



























* See Table 1. footnotes b, c, and d.
single itnmunizalion. Rabbits immunized with heat-killed 
vaccines showed a rapid and elevated anti PS response 
which persisted through day 28. The anti-PS responses in 
rabbits immunized with PS BOO conjugates were delayed in 
comparison; however, high PHA liters to PS were produced 
in these animals by day 30. and the antibody activity 
persisted through day 50. PS-BGG conjugate-immunized 
animals were exsanguinated 50 to 60 days postimmunization.
Polysaccharide was used as an immunogen to produce a 
high-tiler antiserum to Ihe PS O-antigen in the Vibrio cell 
wall which would be serologically reactive with only those 
vibrios which express that O-antigen determinant. To assess 
Ihe serological specificity of each anti-PS serum produced 
against the eight non-01 serovars and two PI strains, (he 
liters of these sera were determined by PHA in a checker­
board fashion (Table 4).
The PHA tilers suggest that each of the eight non-01 
vaccine strains possesses a unique (serovai-specific) LPS- 
associated antigen. In addition, either vaccine strains O and 
Q share a second minor LPS antigen, or each vaccine strain 
expresses the Q- and O-antigen. respectively, at a low 
concentration. Vaccine strain XX probably expresses anti­
gen X. whereas strain X does not express detectable levels 
o f antigen XX. When a simitar serological checkerboard 
titration was done by testing the anti-PS sera with live cell 
suspensions o f the vaccine strains by slide agglutination, an 
identical result pattern was seen.
The eight environmental isolates were retested by slide 
agglutination in each of the 10 anti-PS sera (Table 5). Isolate 
La 8584 had agglutinated in both anti-non-Ol XX serum and 
anti-Ol serum produced in rabbits immunized with heat-
killed whole-cell vaccines (Table 2). whereas LPS extracted 
from this isolate was agglutinated by PHA in anti-Ol serum 
only (Table 3). When anti-PS serum was used to retest this 
isolate by slide agglutination, a live suspension o f La 8584 
cells was agglutinated in anti-Ol serum only. The slide 
agglutination patterns o f (he eight environmental isolates in 
the anti-PS serum (Table 5) parallel the PHA results when 
LPS o f each isolate was tested in antisera raised in rabbits 
immunized with heat-killed whole-cell vaccines (Table 3). 
The single exception was La 6169. which agglutinated in 
anti-PS serovar Q. The anti-LPS PHA titers (Table 4) imply 
that vaccine strains X and XX share at least one LPS 
antigen, a finding substantiated in environmental isolates. 
The anti-PS sera provide a level o f specificity in slide 
agglutination comparable to that o f the PHA test, which 
improves upon the presently used lyping sera produced in 
rabbits immunized with whole-cell vaccines.
DISCUSSION
It was not our intention to add a third serological typing 
scheme and its inherent nomenclature to the two systems 
presently in use (9. 11). The lyping scrum we have used to 
serologically examine thousands of environmental V. cho- 
I tra f isolates (7) was prepared by using the methods of 
Sakazaki (9). It became apparent that typing sera raised in 
rabbits immunized with heat-killed whole-cell vaccines did 
not possess the specificity necessary to serologically dis­
criminate between non-Ol serotypes and serovars (Table 2).
One plausible explanation for the apparent lack o f correla­
tion between the two currently used serological typing 
schemes originates with the disparity in Ihe methods used to
TABLE 5. Reexamination o f V. cbolrrat isolates by slide agglutination in anti-PS serovar-specific sera
Live V. rM m r Slide aaalulinalion reaction* in aniiserum to PS-BGG conioxsles of:
suspensions of: q* O 0  X V FF UU XX 01
La 8584 0 44
La 6480 44 0
La 9214 0 44
La 9296 0 •S + 0 44
La 6169 + + 0
La 6195 + 4
La 9313 0 ♦ + 0 44
La 9302 0 + 4 0 44
* 4 "f. Agglutination in optimal dilutions o f anirserum within I min; + . agglutination in low dilutions o f aniiserum within 1 min.
* See Talrle 1. footnotes b, c. and d.
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prepare vaccines. The diverse melhodology is further 
clouded by Ihe fad that neither Ihe Sakazaki nor the Smith 
system attempts to define or identify the serovar seroiype- 
specific antigenfs) that each system puriwrts to detect. It is 
probable that each system may be detecting diflerent classes 
of antigens, a conclusion one might reach when examining 
the efforts o f Brenner et al. (1) to correlate the two systems. 
From our vantage point it appears that the serological 
nomenclatures, serovar or serotype notations, of the two 
systems are irreconcilable. Whole-cell vaccines, living or 
heat killed, present a diverse oflering o f serovar-specific and 
non-serovar-specific antigens to the antibody-producing fa­
cilities of rabbits, resulting in the production of a spectrum of 
antibodies possessing an array of specificities. This appears 
to be the case when the two environmental V. cholerae 
isolates. La 8584 and La 9214. were serologically tested with 
serum produced in rabbits immunized with heat killed 
whole-cell vaccines. These isolates agglutinated in optimal 
dilutions of anii-OI serum and anti-non-Ol serum XX. Hie 
public health implications are significantly greater if  V. 
cholerae O l organisms are recovered from recreational 
waters, seafood, or sewerage than if  non-Ol isolates are 
detected. I f  the typing serum fails to discriminate among the 
0-antigens, then a breakdown in the follow-up toxigenic 
studies and resulting interpretations ensues.
To us it makes good sense to dedicate or commit the 
serological typing o f V. cholerae to the detection of LPS 
associated antigens for reasons previously presented. This 
approach could lead to a standardized serological nomencla­
ture which defines the cell wall component which carries the 
serovar-specific antigen. Antisera which exhibit specificity 
for LPS associated antigens of eight non-OI and two 01 
serovars were produced in rabbits immunized with the PS 
moiety of LPS prepared from each serovar and conjugated to 
a protein carrier. A high-tiler antibody was produced after 
two immunizations, with slide agglutination titers equal to 
and often four times the level seen in sera produced in 
rabbits immunized with whole-cell vaccines; and in each 
case anti-PS sera showed specificity for homologous LPS. In 
three instances it appears that either a second LPS-associat­
ed antigen may be shared by two vaccine strains (i.e., O and 
Q (Table 4]) or each strain expresses at a low concentration 
the reciprocal serovar-specific antigen. The question could 
be resolved by absorption studies, and it should not be 
surprising for non-Ol strains to express multiple LPS deter­
minants since 01 Inaba and Ogawa each express antigen A. 
Both Smith (12) and Shimada and Sakazaki (10) detected 
cross-reactions in their respective antisera and conducted 
absorption studies which implied the existence o f multiple 
O-antigen determinants on V. cholerae non-01. When iso­
lates La 8584 and La 9214 were tested by slide agglutination 
in anti-PS sera, they each agglutinated in anti-Ol only (Table 
5), which wax not Ihe case when these isolates were tested in 
antisera raised in rabbits immunized with whole-cell vac­
cines (Table 2). The slide agglutination patterns o f the eight 
environmental V. cholerae isolates in anti-PS sera paralleled 
the PHA patterns obtained when anti-whole cell sera were 
tested against LPS extracted from these same eight isolates. 
These findings suggest that anti-whole-cell sera, when tested 
against live or Formalin-killed cell suspensions by slide 
agglutination, react with a heat-stable non-LPS antigenfs) 
shared across serovar boundaries.
At this time neither the efficiency of the PS conjugation 
process nor the molecular size of the PS moiety conjugated 
to the protein carrier is known, nor have Ihe constitutive 
sugars that comprise the 0-determinants in the non-Ol
strains been identified. However, in the absence o f this 
information, preliminary findings suggest that the PS-BCG 
corrugate as an immunogen is superior to native LPS. 
Rabbits immunized with O l and non-Ol LPS by intraperito- 
neal or subcutaneous injection yielded low and transitory 
PHA and slide agglutination titers (R. J. Siebeling, L. B. 
Adams, Z. Yusof, and A. D. Larson, Proceedings o f the 
Cotference on Vibrios in Ihe Enxironmeni, in press). Staub 
(13) prepared LPS-RBC stromata immunogens with Salmo­
nella LPS and successfully produced anti-LPS activity in 
rabbits, an approach which was not consistently reproduc­
ible when we used V. cholerae non-01 LPS-stromata or 
LPS-whole RBC as immunogens (Siebeling et al., in press). 
It is conceivable that the PS BCG immunogen described and 
the immunization regimen used can be improved upon by 
determining the optimum PS to BOG coupling ratio, identi­
fying the O-determinant in crude PS. identifying a more 
efficient carrier, and evaluating diflerent immunogen doses 
and immunization schedules.
One approach that could be followed to unify the serologi­
cal nomenclature used to identify V. cholerae non-Ol groups 
(serovars-serotypes) could he done in the following manner. 
LPS, if  it is agreed that the serovar-specific antigen resides 
in̂  this cell wall constituent, could be extracted from the 
vaccine strains of either the Smith or the Sakazaki collec­
tion. RBC coated with LPS would he tested by PHA with the 
homologous and heterologous typing sera in that collection. 
In this manner the minimum number o f unique LPS-associat­
ed antigens in (he collection can he serologically identified. 
Determinants that may be shared among serovars. in the 
manner that the A-determinant is shared by the Inaba. 
Ogawa. and Hikojima serovars in the 01 group, may be 
identified. Next, the typing serum in (he opposite collection 
would be used to serologically test the LPS-sensitized RBC 
in an attempt to identify its counterpart in the first collection. 
In addition, serogroups unique to each collection would be 
recognized, a finding reported by Brenner et al. (I).
ACKNOWLEDCMENTS
This research was supported in part by the Louisiana Sea Grant 
College Program, a part o f the National Sea Grant College Program 
maintained by (he National Oceanic and Atmospheric Administra­
tion. U.S. Department o f Commerce (grant NA 79 AA-D-00128). 
The Louisiana Program is administered by the Center for Wetland 
Resources, Ixniisiana Stale University. Baton Rouge.
We gratefully acknowledge Tina Teague and Bobbie Nielsen for 
secretarial assistance in Ihe preparation o f this manuscript.
LITERATURE CITED
1. Brenner, D. j  . B. R. Da vis, V. Kodoli, M. Ohashl, R SaltaukI, 
T . Shhntda, and H. L, Smltli, Jr, 1982. Serological comparison 
o f two cntleclions o f Vihrio cholerae non 01 L Clin. Microbiol. 
I6.-319-Î2Î.
2. Gardner, A. D., and K. V. Venkatraman. 191). The antigens of 
Ihe cholera group o f vibrios. J. Ilyg. .15:262-282.
3. Kaper, J. B., II. B. Bradford, N. C. Rolirrts, and S. Falkow. 
1982. Molecular epidemiology o f Vibrio cholerae in Ihe U.S. 
Gulf Coast. J. Clin. Microbiol. 16:129-1)4
4. LeMlnor, L. 1981. The genus Salmonella, p. 1148-1159. In 
M. P. Starr. H Stols, H. G. Truper, A. Ballows. and H. G. 
SchlegeKed.l. The procaryotes, vol. 2. Springer-Verlag, Berlin.
5. Redmond, J. W. 1979. The structure o f the O antigenic side 
chain o f the lipopolysaccharide o f Vihrio cholerae 569B (Inaba) 
Biochim. Biophys. Acta 584:346-352.
6. Redmond, J. W ., M. J. Koneh, and G. 0 . F. Jacluon. 1973. 
Immunochemical studies o f the 0-antigens of Vihrio cholerae. 
Partial characterization o f an acid labile antigenic determinant.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
15
ADAMS AND SIEBELING J. Cu n . Micnomoi
A «jl. J, E ip. Biol. Med. Sci. 5I:2W-2.I.'.
7. K«bei<i , N. € .. K. J. SkheBn#. J. B. K«prr. «*d H. B. Br»df«ed. 12
Sr. IW2. Vibfios in Ihe Louisiira Gulf const environment.
Mtcfob. Ecol. 1:299-312. 
t .  Snkaahl, R., and T. SMmadn. 1977. Scrovnrs o f Vihrio rho- 
k n t .  Jpn. J. Med Sci. B id . 39:279-2112. 13.
9. Snkaahl, R., K. Tamnra, C Z. Cnmem. and R. Sen. 1970. 
Seeobgicnl (Indies on the cholera poop o f vibrioi. Jpn. J. Med.
Sci. Biol. 23:13-20.
10. Shhnada, T „ and R. Snkaahl. 1977. Additional serovars and 
intee-O antipenic eelationships of Vihrio tholtror. Jpn. J. Med. 14. 
Sci. BM. 39:273-277.
11. Sndth, H. L., Jr. 1979. Serotypimp o f non cholera vibrios. J
Clin Microbiol. 19:95-90.
Smith, H. L., J r., and K. Coodner. 1965. On the classilkatioo of 
vibrios, p. 4-9. fm O A. Bushnell and C. S. Biookhyser led.). 
Procecdinps o f the Cholera Research Symposium, Honolulu, 
Hasvaii.
Stanb, A. M. 1964. The role o f Ihe polysaccharide moiety in 
delermininp the speciOcily and immunolopical activity o f the O 
antipen cornpks in Salmonellae, p. 39-41. Jn M. Landry and W. 
Braun (ed.l. Bacterial endotoxins. Academic Press Inc., New 
York.
Wealphal, 0 „  and K. Jana. 1963. Bacterial lipopolysaceharides. 
Extraction srith phenol svater and further apfrfkations o f the 
procedure. Methods Carhohydr. Chem. 5:93-91.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER II Production of monoclonal antibodies
directed against the lipopolysaccharide 
antigens of Vi brio chole rae 01.
16
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
A: . .
INTRODUCTION
In the effort to produce highly specific typing 
antisera, it has traditionally been the approach of the 
aerologist to use an immunogen of the greatest possible 
purity. The elimination of extraneous antigens in the 
vaccine usually required utilization of elaborate 
techniques, for minute amounts of contaminating materials 
could elicit antibody levels that were extraordinarily 
high (Deutsch, 1967), In addition, the laborious task of 
absorbing out the various unwanted antibodies was often 
accompanied by a drop in titer toward the antigen of 
interest. On the other hand, ultrapurification of some 
substances often rendered them less immunogenic because 
unwanted proteins often acted as a carrier, or schlepper. 
For example, purified bacterial polysaccharide generally 
induced low antibody responses, whereas immunization with 
the intact whole cells resulted in copious 
anti-polysaccharide activity (Staub, 1967). In such 
instances, unrelated carriers were often utilized with 
the hopes that the antibody activity against the carrier 
would not interfere, i.e., cross-react, in the 
serological test employed, or, if so, such activity could 
be easily removed (Staub, 1964). Therefore, a primary 
concern of the aerologist had invariably been the quality
17
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of the vaccine when preparing antisera for typing 
purposes.
In 1975, Kohler and Milstein greatly altered the 
paradigms of immunology by introducing the technique for 
preparing monoclonal antibodies. Spleen cells from mice 
immunized with a potent antigen, sheep erythrocytes, were 
fused iji v itro with cells of the mouse myeloma cell line, 
P3X63-Ag8. This cell line was unable to synthesize 
nucleotides by the salvage pathway due to a defective 
hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) 
enzyme « By growing the fusion mixture in medium 
supplemented with aminopterin, which blocks de novo 
purine and pyrimidine synthesis, hypoxanthine, and 
thymidine (Littlefield, 1964), they were able to select 
for hybrid cells, or hybridomas, which exhibited the 
crucial properties of both parent cells: the functional
HGPRTase and anti-sheep erythrocyte antibody producing 
capability of the spleen cell and the immortality of the 
myeloma cell. It is important to note that in their 
procedure, the immunogen was crude; but, by the cloning 
of these hybridomas, they obtained the ultimate in 
serological specificity for each culture manufactured 
antibodies of a single idiotype.
Since Kohler and Milstein *s original experiment, 
various modifications of their technique have been 
introduced. For example, immunoglobulin negative cell
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lines, such as SP2/0-Agl4 (Shulnan et al., 1978) and 
X63-AgS,653 (Kearney et al., 1979), are now routinely 
used. The FOX-NY myeloma cell line has been employed for 
selectively retaining antibody producing hybridomas 
(Taggart and Samloff, 1983). The FOX-NY cells, which 
possess a defective adenosine phosphoribosyltransferase 
(APRTase) enzyme, are fused with immune spleen cells from 
the Robertsonian (8.12) 5 Bnr mouse, in which the active 
Immunoglobulin heavy chain locus on chromosome 12 is 
genetically linked to the APRTase locus on chromosome 8. 
Functionally active APRTase hybridomas are then selected 
for by adding to the growth medium, azaserine, which 
blocks novo purine synthesis. The result is that 
virtually all of the APRTase positive hybridomas will be 
antibody producing cells because of the translocation. 
Consequently, overgrowth by surviving, non-antibody 
producing hybridomas is essentially eliminated, and 
active antibody producing cells are rarely lost during 
the selection procedure.
Likewise, new fusing agents, such as polyethylene 
glycol (Pontecorvo, 1976) and electric currents 
(Zimmermann and Vienken, 1982) have replaced the Sendai 
virus used initially. Epstein-Barr virus transformation 
(Steinitz et al., 1977) and transfection of tumor cell 
DNA into spleen cells to effect immortalization (Jonak et 
al., 1984) have also been achieved. In addition.
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techniques for developing rat (Clark et al., 1983) and 
human (Olsson et al., 1983) hybridomas have been 
successful.
Monoclonal antibodies have been produced against a 
vast variety of antigens, including those of Vibrio 
chole ra e . For example, several laboratories (Remmers et 
al., 1982; Robb et al., 1982; Holmes and Twiddy, 1983) 
have established hybridomas secreting monoclonal 
antibodies against the cholera toxin holoenzyme and its 
subunits. These monoclonal antibodies have proven useful 
in toxin neutralization assays (Robb et al., 1982) and in 
studies analyzing the relatedness between cholera toxin 
and E. coli heat-labile toxin (Holmes and Twiddy, 1983).
Monoclonal antibodies have also been prepared 
against V. cholerae lipopolysaccharide (LPS). Gustafsson 
et al., (1982) established a hybridoma cell line 
producing monoclonal antibodies against the core region 
of V . cholerae LPS. Spleen cells from mice which had 
been given repeated injections of purified Inaba LPS were 
fused with the myeloma cell line, P3X-HS-1. Only one 
positive hybridoma resulted. Since these antibodies were 
inhibited, in the ELISA inhibition assay, by the LPS 
extracted from both 01 and non-01 V_̂  cholerae, they 
concluded that the antibodies were specific for the core 
region. These antibodies were also active by 
coagglutination.
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Gustafsson and Holme (1983), later established 
hybridomas which secreted antibodies specific for the A ,
B, and C antigens of cholerae 01 LPS. The three 
hybridomas were derived from three different fusion 
experiments which utilized the SP2/0-Agl4 myeloma cell 
line. Spleen cells harvested from mice immunized with V . 
cholerae 35 Inaba LPS resulted in one anti-A secreting 
hybridoma, those from mice immunized with cholerae 34 
Ogawa LPS resulted in one secreting anti-B antibodies, 
and those from mice immunized with cholerae 569B Inaba 
LPS resulted in one secreting anti-C antibodies. The 
specificity of each of these monoclonal antibodies was 
determined by ELISA inhibition and limited slide 
agglutination.
Sciortino et al. (1985) established a library of 66 
hybridomas against outer membrane antigens of cholerae 
01. Of these, 26 produced antibodies against the LPS. 
None, however, distinguished the Inaba and Ogawa 
serotypes. Furthermore, only three of the anti-LPS 
monoclonal antibodies possessed agglutinating activity.
The purpose of this investigation was to establish 
hybridomas secreting monoclonal antibodies against the 
LPS antigens of cholerae 01. These hybridomas were 
isolated, cloned, and their performances in enzyme linked 
immunosorbent assays were evaluated. They were then 
frozen so to obtain endless supplies of high titer.
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monospecific serotyping reagents.
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MATERIALS AND METHODS
Preparation of lipopolysaccharide (LPS). LPS was 
extracted from three cholerae 01 Inaba strains (ATCC 
14033, LA 5875, CA 401), two 01 Ogawa strains (CA 411 and 
ATCC 14035), and one non-01 strain (XX [Fla 45]) by the 
method of Westphal and Jann (1965). Overnight cultures 
of cholerae were harvested from trypticase soy agar 
(Difco Laboratories, Detroit, MI) flats in Roux flasks, 
and the cell suspensions were washed three times in 0.15 
M NaCl. The cells were dried in acetone, resuspended in 
deionized water at 1 g/17.5 ml, and extracted in an equal 
volume of 90% phenol at 68*C for 15 min. The mixture 
was cooled to 10*C and centrifuged at 1085 x g for 45 
min. The aqueous layer which contained LPS was removed, 
and the phenol layer and insoluble fraction were 
re-extracted in deionized water. The aqueous extracts 
were pooled, dialyzed extensively against deionized water 
to remove phenol, and then lyophilized. The crude LPS 
preparation was dissolved in deionized water to yield a 
1% (wt/vol) solution and centrifuged one time at 80,000 x 
g for 6 to 3 h and two times at 105,000 x g for 3 h to 
pellet the LPS, leaving residual ribonucleic acid in 
solution. The pellet was dissolved in a small volume of 
deionized water and lyophilized.
23
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Vaccine preparation and immunization protocols. LPS 
vaccine. LPS was dissolved in 0.15 M NaCl (500 ug/0.5 
ml) and emulsified in an equal volume of Freund Complete 
Adjuvant (FCA) (Difco). One hundred ul were inoculated 
subcutaneously into female Balb/c mice 6 to 8 weeks of 
age. The mice were boosted twice at monthly intervals 
with 100 ul LPS in 0.15 M NaCl (100 ug/lOO ul) by 
intraperitoneal injection and exsanguinated by cardiac 
puncture four days after the last injection.
Polysaccharide-protein carrier conjugate v accine. 
Polysaccharide-protein carrier conjugates were prepared 
as reported by Adams and Siebeling (1984; Chapter I, this 
dissertation). The conjugate was dissolved in 0.15 M 
NaCl (500 ug/0.5 ml) and mixed with an equal volume of 
FCA. Female Balb/c mice were immunized with 100 ul of 
the emulsion by subcutaneous injection. One month later, 
the mice were boosted subcutaneously with 100 ul of the 
vaccine emulsified in Freund Incomplete Adjuvant (FIA) 
(Difco). Three weeks later, the mice were given 100 ul 
of the conjugate dissolved in 0.15 M NaCl (100 u g / 100 ul) 
by intraperitoneal injection and exsanguinated four days 
later.
Formolized whole cell vaccine. Formolized whole 
cell vaccines were prepared by the method of 
Bhattacharyya (1977). V. cholerae 01 were grown on 
trypticase soy agar at 3 7 "C for 24 h. The cells were
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suspended in 0.3% formolized-0.067 M phosphate buffered 
saline, pH 7.3 (PBS) and stored at 4*C for 48 h. The 
suspension was standardized in PBS to either 80 units or 
380 units in a Klett-Summerson colorimeter at 540 nm. 
Female Balb/c mice were given graded doses 
intraperitoneally every four to five days for 
approximately one month. The mice were exsanguinated 
four days after the last boost.
Heat-killed whole cell vaccine. Heat-killed whole 
cell vaccines were prepared by the method of Sakasaki et 
al. (1970). V. cholerae 01 were grown on trypticase soy 
agar in a Kolle flask at 37*C for 24 h. Cells were 
harvested in 25 ml 0.15 M NaCl and heated in a 100"C 
water bath for 2 h. The suspension was centrifuged at 
3000 X g for 20 min and washed one time in saline. The 
vaccine was standardized in 0.15 M NaCl to 116 units in a 
Klett-Summerson colorimeter at 660 nm. Female Balb/c 
mice were immunized by the same immunization regime as 
for formolized whole cell vaccines.
Thymocyte feeder layers. Mouse thymocytes used for 
feeder layers were obtained from 3 to 4 week old male 
Balb/c mice. A mouse was asphyxiated in a chamber of 
flowing N^ gas for 2 min, immersed in 70% ethanol, and 
placed in a sterile dish. All subsequent manipulations 
were performed in a laminar flow hood (Baker Co., Inc.,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
26
Stanford, ME) using sterile technique.
A small incision was made just below the sternum, 
and the skin was pulled back with forceps to expose the 
chest cavity and abdomen. Each rib was cut on one side 
of the sternum, taking care not to puncture the heart.
By inserting the tip of the scissors into the incision, 
the rib cage was retracted by opening the scissors, 
thereby exposing the thorax. The thymus lobes, which lie 
immediately anterior to the heart, were removed with 
forceps, transferred to a 50 ml centrifuge tube, and 
immersed in 10 ml calcium and magnesium free Hank's 
balanced salt solution (CMF-HBSS) (0.4 g/L KCl, 0.06 g/L 
K H g P O ^ , 8.0 g/L NaCl, 0.09 g/L Na^PO^.7HgO, 1.0 g/L 
glucose, 0.35 g/L NaHCO^, pH 7). After 5 min, the 
CMF-HBSS was decanted, and the intact thymus was washed 
two times more.
The thymus was transferred to a Petri dish and 
minced with scissors to free individual thymocytes. Ten 
ml CMF-HBSS was added, and the thymocyte suspension was 
aspirated and delivered to a 15 ml conical centrifuge 
tube. The large tissue fragments were permitted to 
settle, and then the thymocyte suspension was decanted 
into a second tube and the cells sedimented at 200 x g 
for 10 min. The supernatant fluid was decanted, and the 
thymocyte pellet was washed two times with 10 ml CMF-HBSS 
and resuspended to a concentration of 2 x 10^ cells/ml in
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growth medium (RPMI 1640 [GIBCO, Grand Island, NY] 
buffered with NaHCO^ and supplemented with 15% fetal 
bovine serum [GIBCO], 2 mM L-glutamine [Sigma Chemical 
Co., St. Louis, MO], 1% MEM non-essential amino acids 
[Hazleton Research Products, Inc., Denver, PA], 10 
units/ml penicillin, 10 ug/ml streptomycin, pH 7). The 
thymocyte suspension was distributed to each of the 96 
wells in a tissue culture plate (Corning Laboratory 
Sciences Co., Corning, NY) in aliquots of 0.1 ml (one 
drop from a 10 ml pipette) per well. The thymocytes were 
incubated at 37"C in an atmosphere of 7.5% CO^ in air.
One mouse thymus provided sufficient cells to seed five 
tissue culture plates.
Cell fusion. The fusion procedure, in which immune 
mouse spleen cells were fused with myeloma cells, was 
performed by the protocols of Oi and Herzenberg, (1980) 
and Dr. K.L. Schnorr (Dept, of Veterinary Microbiology 
and Parasitology, School of Veterinary Medicine, LSU, 
personal communication).
Myeloma cells. Four days prior to fusion, 200 ml of 
growth medium was seeded with 8-azaguanine-resistant, 
Ig-negative SP2/0-Ag 14 myeloma cells (Shulman et al., 
1978) to give 1 x 10^ cells/ml. The cells were incubated 
at 37*C in an atmosphere of 7.5% CO^ in air. It was 
determined previously that this manipulation would yield
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7approximately 6 x 10 cells on the day of the fusion.
Just prior to fusion, the myeloma cells were pelleted at 
200 X g for 10 min and washed two times with 30 ml 
CMF-HBSS. The washed myeloma cells were resuspended in 
30 ml of serum-free growth medium and counted.
Spleen cells. Mice primed with cholerae 01 
vaccine were asphyxiated and then exsanguinated by 
cardiac puncture using a l e e  syringe fitted with a 25 g 
needle. The immune serum was harvested by standard 
methods and stored at -20*0. The mouse was immersed in 
70% ethanol, placed in a sterile dish, and the spleen 
removed from the peritoneal cavity in the following 
manner.
The mouse was skinned and the peritoneum was cut 
away to expose the spleen, which lies in the left upper 
quandrant immediately posterior to the diaphragm. Care 
was taken so as not to puncture the intestine. The 
spleen was lifted from the peritoneal cavity, cut free 
from the surrounding omentum, and transferred to a 50 ml 
conical centrifuge tube containing 10 ml CMF-HBSS. The 
CMF-HBSS was decanted after 5 min, and the spleen was 
washed two times more. Next, the spleen was transferred 
to a Petri dish containing 10 ml CMF-HBSS and cut 
transversly into five segments. Individual spleen cells 
were released from each fragment by gently squeezing each 
segment with grooved forceps. The spleen cell suspension
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was collected and delivered Into a 15 ml conical 
centrifuge tube, and the Petri dish was rinsed with 5 ml 
CMF-HBSS. The pooled spleen cell suspensions were 
pelleted at 200 x g for 10 min, washed two times more 
with 15 ml CMF-HBSS each, re suspended in 10 ml serum-free 
growth medium, and counted. One spleen yielded
g
approximately 1 x 1 0  cells.
Fusion protocol. The spleen cells and myeloma cells 
were mixed to give a ratio of 4:1 respectively and 
centrifuged at 200 x g for 10 min. The serum-free 
supernatant fluid was decanted, and the cell pellet 
loosened. Cell fusion was effected through the addition 
of 50% polyethylene glycol 3000-3700 (PEG) (ATCC, 
Rockville, M D ) . The PEG reagent was prepared by first 
melting 2 g PEG in a 56*C water bath and then adding 2 
ml RPMI 1640 with NaHCO^ which had been warmed to 37"C. 
This reagent was stored at 4"C .
Immediately prior to fusion, the PEG solution was 
warmed to 37*C. A "make-shift" 37*C water bath was 
constructed by placing a 100 ml beaker inside a 400 ml 
beaker, each filled with water from the 37*C water 
bath. The centrifuge tube containing the spleen 
cell-myeloma cell mixture was placed in the 100 ml
g
beaker. For each 1.6 x 10 spleen cells present, 1 ml of 
PEG reagent was added, dropwise with gentle stirring, 
over a 1 min time interval. The cell mixture was stirred
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for an additional minute, and then 10 ml growth medium 
was added, dropwise with stirring, over 4 min. The 
growth medium was added very slowly at first, to avoid 
osmotic shock and lysis of the cells. The cells were 
centrifuged at 200 x g for 10 min and resuspended in 
growth medium to give 7.5 x 10^ spleen cells/ml. Next, 
0.1 ml fused cells were very carefully distributed to 
each well of the tissue culture plates which contained 
the thymocyte feeder layers. The plates were incubated 
at 37"C in an atmosphere of 7.5% C O2 in air. The day 
of fusion was defined as day 0.
On day 1, the cells in each well were fed 0.1 ml 
growth medium supplemented with 0.1 mM hypoxanthine 
(Sigma), 4 X 10 ^ mM aminopterin (Sigma), and 1.6 x 10 ^ 
mM thymidine (Sigma) (HAT medium) (Littlefield, 1964).
On days 2, 3, and 4, approximately 0.1 ml of culture 
fluid was removed from each well and replaced with fresh 
HAT medium. On days 5, 6, 7, and 8, the cells were fed 
growth medium supplemented with hypoxanthine and 
thymidine only (HT medium). The cultures were then fed 
with HT medium every two to three days.
Enzyme linked immunosorbent assay (ELISA). LPS 
ELISA. The ELISA procedure used to identify antibody 
activity specific for LPS was modified from the 
procedures described by Schreier et al. (1980) and Voiler
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
31
et al* (1976)* Each well of a 96 well flat bottomed 
polyvinyl chloride (PVC) microtiter plate (Dynatech 
Laboratories, Alexandria, VA) was coated with 50 ul of 
LPS solution (50 ug/ml) in phosphate buffered saline 
(PBS-Az) (8.0 g/L NaCl, 0.2 g/L KH^PO^, 1.2 g/L Na^PO^,
0.2 g/L KCl, 0.2 g/L N a N j , pH 7.2). Negative control 
wells were coated with PBS-Az alone. The plates were 
incubated, uncovered, at 37*C overnight to dehydrate 
each well. Each well was washed one time by dispensing 
0.2 ml PBS-Az to each well with a Cornwall syringe or a 
Dynatech Miniwash (Dynatech) and incubated for three 
minutes .
Next, the uncoated sites in each well were blocked 
by the addition of 200 ul 2% bovine serum albumin (BSA) 
(Sigma) in PBS-Az. The covered culture plate was floated 
in a water bath at 37 "C for 2 h. The wells were washed 
one time with PBS-Az. Fifty ul of hybridoma culture 
supernatant fluid were added to each well. Negative 
control wells received growth medium or normal mouse 
serum while positive control wells received immune mouse 
serum. The plates were floated in a 37 ° C water bath 
for 1 h, and each well was then washed four times with 
PBS-Az.
In the next step, 50 ul of goat anti-mouse Ig (IgG, 
IgM, and IgA) conjugated with alkaline phosphatase 
(Kirkegaard and Perry Laboratories, Gaithersberg, MD)
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were added to each well. The conjugate was used at a 
1:200 dilution in 1% BSA in PBS-Az. The covered plate 
was floated in a water bath at 37"C for 1 h and then 
washed five times with PBS-Az.
Finally, 200 ul p-nitrophenyl phosphate (1 mg/ml) 
(Sigma 104 Phosphatase Substrate, Sigma) in 
diethanolamine buffer (97 ml diethanolamine, 0.2 g/L 
NaN^, 0.1 g/L MgClg* ô H^O, pH 9.8, stored in the dark at 
4 * 0  were added to each well and incubated, in the 
dark, at 37 * C for 30 min. The enzyme-substrate 
reaction was stopped by the addition of 25 ul 3 N NaOH to
each well. The absorbance, at 405 nm, was read and
recorded by an EIA Reader (Bio-Tek Instruments, Inc.).
An absorbance greater than 0.200, the color which can be 
discerned visually, was considered positive, since the 
fluid in negative control wells gave absorbance readings 
of less than 0.100.
Whole cell ELISA. A whole cell ELISA procedure was
also used. In this assay, each well of an Immulon II
microtiter plate (Dynatech) was coated with 50 ul of a 
fresh bacterial suspension adjusted to 6 x 10^ cells/ml 
in PBS-Az and incubated, uncovered, at 37 *C overnight.
All subsequent steps in the ELISA were carried out as 
described above.
Limiting dilutions. Hybridoma cultures found
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positive by ELISA were cloned by the limiting dilution 
procedure (Oi and Herzenberg, 1980; Dr. K.L. Schnorr, 
personal communication). The objective was to obtain a 
population of cells which had arisen from a single 
MAb-secreting hybridoma cell by subculturing dilutions of 
the original mixed culture.
The hybridoma cells were resuspended in the well of 
the master plate. One half of the suspension (100 ul) 
was transferred to a snap cap tube (Falcon, Cockeysville, 
MD) which contained 0.8 ml HT medium, and then counted. 
Following an intermediate dilution of 1:40, the cells 
were diluted in HT medium so that a 5.0 ml suspension 
contained 40 cells/ml. This suspension was serially 
diluted three times, and each cell dilution was 
distributed, in 0.1 ml aliquots, to the 24 wells in two 
rows of a 96 well plate which contained a thymocyte 
feeder layer. This manipulation yielded cultures of 
approximately 4 hybridomas/well, 2 hybridomas/well, 1 
hybridoma/we11, and 0.5 hybridoma/well. The plates were 
incubated at 37*C in an atmosphere of 7.5% COg in air.
After one week, those wells which contained one 
colony were fed with HT medium. Two to three days later, 
the culture supernatant fluids from those wells were 
assayed by ELISA. The culture which exhibited the 
highest absorbance value was subjected to a second and 
third limiting dilution round. It was assumed that the
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hybrldoma cell line was cloned when 100% of the wells 
tested were positive.
Hybrldoma expansion and maintenance. Following the
last limiting dilution, the cloned hybrldoma culture was
expanded. The cells were resuspended and transferred
into 2 ml growth medium in a 24 well tissue culture
plate. When growth was confluent over the well floor,
the cells were resuspended and transferred into 5 ml
2growth medium in a 25 cm tissue culture flask. Each 
clone was maintained by transferring 0.1 ml of cell 
suspension into 10 ml fresh growth medium every four to 
five days, which kept the cells in log phase growth.
Immunoglobulin isotyping. Each MAb was isotyped by 
ELISA using the HyClone Sub-Isotyping Kit (HyClone 
Laboratories, Salt Lake City, UT).
Freezing of hybridomas. Fifty ml growth medium were 
seeded with 1 x 10^ cells/ml and incubated at 37*0 in 
an atmosphere of 7.5% COg in air for four days. The 
cells were pelleted at 200 x g for 10 min and resuspended 
in freezing medium (RPMI 1640 buffered with NaHCOg and 
supplemented with 20% fetal bovine serum, 2 mM 
L-glutamine, 1% MEM non-essential amino acids, 10 
units/ml penicillin, 10 ug/ml streptomycin, 10% dimethyl
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sulfoxide, filter sterilized) at a concentration of 2 to 
6 X 10^ cells/ml. One ml of cell suspension was 
dispensed into vials and frozen at a rate of l*C/min to 
-70'C in an automatic cell freezer. The vials were 
stored in liquid nitrogen at -175*C.
Thawing of hybridomas. The vial which contained the
clone of interest was thawed rapidly in a 37*C water
bath, and the cell suspension was transferred to a 50 ml
conical centrifuge tube. Ten ml growth medium was added,
very slowly at first, with gentle stirring over a 4 min
period. The cell suspension was centrifuged at 200 x g
for 10 min, and the pellet was resuspended in 5 ml growth
2medium and transferred to a 25 cm tissue culture flask. 
The cells were incubated at 37'C in an atmosphere of 
7.5% COg in air and maintained as described above.
Expansion of hybridoma cultures for antibody 
production. Two hundred milliliters of growth medium 
were inoculated with cells to achieve 1 x 10^ cells/ml 
and the cultures were incubated at 37*C in an 
atmosphere of 7.5% COg in air. After seven days 
incubation, when the cells are dying and the antibody 
concentration in the culture fluid is at peak levels, the 
cells were pelleted at 500 x g for 15 min, and the 
supernatant fluid was decanted and stored at -20'C.
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Production of ascites fluid. Growth medium was 
seeded with 1 x 10^ cells/ml and Incubated at 37“C In 
an atmosphere of 7.5% COg In air for four days. The log 
phase cells were counted and then pelleted at 200 x g for 
10 min. The supernatant fluid was discarded and the 
cells resuspended In RPMI 1640 with NaHCO^ at 5 x 10^ 
cells/ml. The cell suspension was Injected 
Intraperltoneally Into female Balb/c mice (0.5 ml per 
mouse) which had been primed with 0.5 ml Prlstane 
(2,4 ,10,14-tetramethylpentadecane) (Sigma) ten and three 
days before.
Ascites fluid accumulated usually within one week. 
The fluid was tapped by Inserting an 18 g needle Into the 
peritoneal cavity and draining the fluid Into a tube.
The ascites fluid was clarified by centrifugation at 
80,000 X g for 30 min and stored at -20*C.
Purification of IgG. Monoclonal antibodies of the 
IgG Isotype were purified on a Protein A-Sepharose CL-4B 
column (Pharmacia Biotechnology Products, Plscataway, NJ) 
by the method of Ey et al. (1978). First, NaN^ (0.02%) 
was added to the clarified supernatant fluid, and the pH 
was adjusted to 8.0 with 1 N NaOH. The supernatant fluid 
was percolated through the column at a flow rate of 10 
ml/h. The column was washed with 50 ml 0.1 M phosphate
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buffer, pH 8.0. The bound immunoglobulins were released 
from the protein A by lowering the pH. IgGl, IgG2b, and 
IgG3 were eluted with 0.1 M citrate buffer, pH 4.5. One 
ml fractions were collected and assayed for absorbance at 
280 nm. The fractions were pooled and dlalyzed against 
PBS-Az at 4*C and stored In 2 ml aliquots at -20*C.
The column was washed with 10 ml 0.1 M glacial acetic 
acld-0.13 M NaCl and then re-equlllbrated with 50 ml 0.1 
M phosphate buffer, pH 8.0. When Immunoglobulins were 
recovered from ascites fluid, one part 0.5 M phosphate 
buffer, pH 8.0, was added to 4 parts clarified ascites 
fluid and filtered through a 0.45 urn acrodlsk (Gelman 
Sciences, Inc., Ann Arbor, MI). Two ml of this solution 
was slowly percolated Into the column and allowed to 
Incubate for 30 min. The column was washed and the 
Immunoglobulins eluted as above.
Concentration of IgM. Immunoglobulins of the IgM 
Isotype were concentrated by ammonium sulfate 
precipitation (Schreler et al., 1980; Good et al., 1980). 
Two hundred ml aliquots of culture supernatant fluid were 
cooled to 4*0. An equal volume of saturated ammonium 
sulfate solution (4*0) was added slowly, with gentle 
stirring, over a period of several minutes. The 
precipitate was Incubated at 4*0 overnight and 
centrifuged at 5000 x g for 10 min. The supernatant
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fluid was discarded, and the pellet was resuspended in a 
small amount of 20 mM Tris HCl-40 mM NaCl, pH 7.8-7.9, 
dialyzed against 2 to 3 changes of 20 mM Tris HCl-20 mM 
NaCl, pH 7.8-7.9, centrifuged at 15,000 x g for 10 min to 
remove precipited denatured proteins, and stored at 
-20'C. For ascites fluid, three parts PBS were added 
to 1 part clarified ascites fluid and the solution cooled 
to 4*C in an ice bath. An equal volume of saturated 
ammonium sulfate solution (4"C) was added slowly, with 
gentle stirring, over a period of several minutes. The 
solution was incubated on ice for 1 h and centrifuged at 
5000 X g for 10 min. The pellet was resuspended in a 
small volume of 0.1 M phosphate buffer, pH 8.0, and 
dialyzed versus two to three changes of buffer. It was 
then centrifuged at 15,000 x g for 10 min and applied to 
the Protein A-Sepharose CL-4B column to remove mouse IgG. 
The eluted sample was stored at -20*C.
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RESULTS AND DISCUSSION
Prior to this point, the rabbit served as the source 
of polyclonal serovar-specific anti-V. cholerae serum, 
but MAb-producing hybridomas have been successfully 
prepared with mouse or rat cells only, and not rabbit 
cells. As a result, the first task was to determine the 
optimum Vjj_ cholerae immunization regimen for mice. Mice 
were immunized with various immunogen preparations, which 
included purified LPS, PS-protein carrier conjugates, and 
whole cells, and the resulting immune sera were 
serologically tested by ELISA (Table 1). Compared to 
rabbits, mice did not produce high levels of anti-V. 
cholerae antibody. Anti-V. cholerae titers in rabbit 
sera ranged from 5 to 8 fold higher than in mouse sera. 
Mice responded best to whole cell vaccines, and, as a 
consequence, mice were primed with whole cell vaccines 
for subsequent fusion experiments.
Table 1 also shows that the whole cell ELISA is more 
sensitive than the LPS ELISA, as titers were generally 
much higher when tested against whole cells. For 
example, sera from mice immunized with cholerae Ogawa 
411 PS-KLH conjugates produced an ELISA titer of 50 when 
tested against Ogawa LPS and a titer of 400 when tested 
against Ogawa whole cells. These findings probably 
reflect a more efficient attachment of the cells to the 
microtiter plate. The type of plate and the pH of the
39
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Table 1. Comparison of antibody responses in mice and 
rabbits immunized with various Vj. cholerae 
immunogens•
antiserum produced
ELISA titers: serum tested against:
in animals 
immunized with: LPS whole cells
mouse 
401 PS-BGG® 200 200
5875 PS-KLH* <50 200
401 A - w h o l e  cells^ 800 6400
14035 LPS® <50 400
411 PS-KLH 50 400
411 f-whole cells'^ <50 6400
14035 f-whole cells 50 3200
14035 A - w h o l e  cells 6400 >12800
rabbit 
401 PS-BGG 6400 >12800
5875 A - w h o l e  cells 6400 >12800
411 PS-BGG >12800 >12800
PS=Polysaccharide, hydrolyzed from 
lipopolysaccharide extracted from V. cholerae Inaba CA 
401, Inaba LA 5875, and Ogawa CA 411 and conjugated with 
bovine gamma globulin (BGG) or keyhole limpet hemocyanin 
(KLH).
^ ^*Heat-killed whole vaccine.
^ LPS»Lipopolysaccharide vaccine. 
f = Formolized whole cell vaccine.
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coating buffer were critical to the coating efficiency of 
the antigen. A coating buffer of neutral or acidic pH 
worked best for LPS, whereas whole cells would also 
attach efficiently in basic carbonate buffer used 
routinely in ELISA (data not shown). The LPS would 
attach consistently to a PVC surface, and not to a 
polystyrene surface. In addition, ELISA protocols often 
call for the addition of a nonionic detergent, such as 
Tween 20, to the wash buffer to prevent non-specific 
binding. This ingredient was omitted from the wash 
buffer because when present, LPS was often lost from the 
wells. Alternatively, non-specific binding of Ig was 
blocked by pretreatment of each well with 2% BSA.
The results of the five successful fusion 
experiments are shown in Table 2. In fusion 1, spleen 
cells from a mouse immunized with formolized LA 5875 
Inaba whole cells (80 Klett units/540 nm) yielded only 1 
positive hybridoma. The hybridoma culture supernatant 
fluid was tested against three cholerae serovars by 
both whole cell and LPS ELISA and reacted with both 01 
and non-01 serovars by whole cell ELISA only. In the 
second fusion, spleen cells from mice immunized in the 
same manner produced two hybridomas secreting antibodies 
which reacted with V_j_ cholerae whole cells. The MAbs 
produced by one clone (A4) reacted with 01 LPS but not 
with non-01 LPS, suggesting that these MAbs were specific 
for the A antigen.
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Specificity5875 411 XX 5875 411 XX
1 A2 ++ +++ ++ 0 0 0
2 A3 ++ ++ ++ 0 0 0
A4 +++ +++ 0 +++ +++ 0 A
3 A6 +++ +++ 0 +++ +++ 0 A
A7 ++ +++ 0 +++ +++ 0 A
A8 ++ ++ 0 ++ ++ 0 A
A9 +++ +++ 0 ++ ++ 0 A
4 AlO 0 ++ 0 0 ++ 0 B
All 0 ++ 0 0 ++ 0 B
A12 + +++ 0 + +++ 0 A
A13 + ++ 0 0 0 0
A14 + ++ + 0 0 0
A15 ++ ++ + 0 0 0
A16 0 + 0 0 0 0
5 A17 ++ ++ ++ 0 0 0
A18 0 0 0 ++ 0 0 C
A19 ++ +++ 0 +++ +++ 0 A
A20 ++ ++ ++ 0 0 0
A21 +++ +++ +++ 0 0 0
A2 2 ++ ++ 0 ++ ++ 0 A




0, ^405^°* ̂ *
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A third fusion was performed with spleen cells from 
mice primed with repeated injections of a heavy 
suspension of formolized ATCC 14035 Ogawa whole cells 
(380 Klett units/540 nm). The fusion resulted in 161 
clones secreting MAbs reactive with whole cells; 
however, only four reacted with LPS. The four MAbs 
reacted with both Inaba and Ogawa LPS, but not non-01 
LPS. They, therefore, were also specific for the A 
antigen.
Fusion 4, in which spleen cells from mice immunized 
with heat-killed ATCC 14035 Ogawa whole cells (116 Klett 
units/660 nm) were fused with the myeloma cells, produced 
7 hybridomas secreting MAbs reactive with cholerae 
whole cells. Three were specific for the LPS.
Monoclonal antibodies secreted by clones AlO and All 
(Table 2) reacted only with Ogawa LPS and were therefore 
specific for the B antigen, whereas clone A12 produced 
MAbs which reacted with both Inaba and Ogawa LPS 
preparations and was directed against antigen A. Unlike 
the five A antigen specific MAbs (fusion 2 and 3), MAbs 
secreted by clone A12 reacted more strongly with Ogawa 
LPS than Inaba LPS. This same reactivity also occurred 
with the corresponding whole cells. Hence, clone A12 
MAbs must react with a different determinant on antigen A 
than the other anti-A MAbs. Monoclonal antibodies 
secreted by A13, A14, and A15 reacted with whole cells 
but not with any of the LPS preparations. Since the
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spleen cells were harvested from mice immunized with 
heat-killed whole cells, these MAbs apparently react with 
a heat-stable, non-LPS antigen present on the whole 
cells.
Fusion 5 used spleen cells harvested from mice 
immunized with heat-killed ATCC 14033 Inaba cells (116 
Klett units/660nm). Twenty four hybridomas were positive 
in the whole cell ELISA but only four reacted with LPS. 
Clones A19, A22, and A23 produced MAbs which reacted with 
LPS extracted from 01 serovars only, so they were 
specific for the A antigen. Monoclonal antibodies 
secreted by clone A18 reacted only with Inaba LPS 
preparations so were specific for the C antigen. Clones 
A 1 7 , A20, and A21 produced MAbs which reacted with both 
01 and non-01 whole cells but not any of the LPS 
preparations, so like A13, A14, and A15 (Fusion 4), they 
reacted with a heat-stable, non-LPS antigen present on 
the cell surface.
Table 3 shows the immunoglobulin isotype of each MAb 
and that a variety of isotypes were produced. Each 
anti-A MAb was an IgG immunoglobulin, except A19 which 
was IgM. Each anti-B MAb (AlO and All) was IgM, whereas 
the anti-C MAb was IgG.
Each MAb was frozen and stored in liquid nitrogen. 
Unfortunately, two MAbs, A8 and A 9 , did not survive this 
manipulation and were lost.
Gustafsson and Holme (1983) produced MAbs directed
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against V. cholerae 01 LPS by fusing spleen cells, from 
mice immunized with purified LPS, with myeloma cells. 
Hybridomas were screened for anti-PS activity by LPS 
ELISA, and the specificity of each MAb for antigen A, B, 
or C was determined by ELISA inhibition. In the study 
presented here, a library of 19 MAbs was established, 
which included MAbs specific for the A (clones A4, A 6 ,
A 7 , A12, A19, A22, and A23), B (clones AlO and All), and 
C (clone A18) antigens of cholerae 01 LPS. Because 
low antibody levels were induced in mice immunized with 
purified LPS or PS-protein carrier conjugates, fusion 
experiments employed spleen cells harvested from mice 
immunized with whole cell vaccines. Anti-PS secreting 
hybridomas were screened by LPS ELISA, and the 
specificity of each MAb for antigen A, B, or C was 
determined by LPS ELISA and whole cell ELISA, rather than 
ELISA inhibition.
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and Immunoelectron microscopy studies 
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INTRODUCTION
In 1973, after more than 50 years without any known 
cases of domestically-acquired cholera in the United 
States, a case of cholera occurred in Port Lavaca, Texas, 
on the Gulf Coast (Weissman et al., 1975), for which no 
source could be identified. In 1978, 11 persons infected 
with Vibrio cholerae 01 were identified in South 
Louisiana, and the infections were traced to ingestion of 
insufficiently cooked crabs which had been trapped in the 
Gulf marshes (Blake et al., 1980). Since the Texas and 
Louisiana cholerae strains were identified as biotype 
El Tor, serovar Inaba, strongly hemolytic, and possessed 
the same unique phage sensitivity pattern and cholera 
toxin gene sequence (Kaper et al., 1982), it was 
suggested that these organisms had persisted during the 
intervening five years and more infections should be 
anticipated. For an undetermined period on September 
20-21, 1981, an inadvertent cross-contamination of a 
sewage-containing canal-water system used for drilling on 
a Texas oil rig and the system used for unchlorinated 
fresh drinking water resulted in 17 cases of cholera 
(Johnston et al., 1983). In August of the same year, two 
East Texas residents who lived 40 miles apart contracted 
cholera (Anonymous, 1981). In 1986, 18 cases of cholera
48
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In Louisiana (Dr. L. McFarland, Chief, Epidemiology 
Section and Dr. P. Lowry, Medical Epidemiologist, State 
of Louisiana, Department of Health and Human Resources, 
personal communication) and one case in Florida 
(Anonymous, 1986) were identified. Each had eaten 
seafood, shrimp, crabs, and raw oysters, within five days 
before onset. Excluding the 1986 isolates which are 
currently being examined, 30 Vj^ cholerae 01 isolates 
recovered from victims, which include a Maryland resident 
(Blake et al., 1983) who contracted cholera while 
vacationing in Cancun, an island off the coast of the 
Yucatan Penisula of Mexico, have been found to be the 
same 01 strain. These findings suggest that this 
organism has persisted along the Gulf Coast for at least 
14 years.
Non-01 cholerae serovars are routinely recovered 
from the estuarine environment (Kaper et al., 1979;
Roberts et al., 1982) while the ultimate reservoir for V . 
cholerae 01 El Tor Inaba along the Gulf Coast has not yet 
been identified. Blake et al. (1980) have suggested that 
the 01 serovars are cyclically transmitted by water and 
food contaminated with feces, and chronic cholerae 01 
carriers may play a role in perpetuating this cycle 
(Azurin et al., 1967; Pierce et al., 1970). Others 
suggest that the 01 serovar may be indigenous to the 
estuarine environment. Vibrio cholerae 01 have been
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Isolated from water in Chesapeake Bay, from sewers and 
saltmarshes in Louisiana (Colwell et al., 1981), from 
oyster meats (Twedt et al., 1981), and from waters in 
Florida (Hood et al., 1981). In each instance, no 
correlation could be drawn between the incidence of V . 
cholerae 01 and fecal coliform numbers in the samples. 
When cholerae 01 were seeded into laboratory 
microcosms, it was reported that conditions such as 
temperature, salinity, and nutrient levels greatly affect 
growth (Singleton et al., 1982a; Singleton et al.,
1982b), morphology (Baker et al., 1983), toxin production 
(Tamplin and Colwell, 1986), and recoverability (Colwell 
et al., 1985) of the 01 organisms. Xu et al. (1984) 
detected cholerae 01 by immunofluorescence in 
environmental samples which were not recovered from these 
specimens by direct or enrichment culture techniques.
They suggested that V̂ . cholerae 01 serovars are 
autochthonous to the estuarine environment and have gone 
undetected by conventional bacteriological methods.
Detection of V_̂  cholerae 01 in environmental samples 
by serological methods has been criticized, and the 
serovar-specificity of polyclonal anti-01 sera has been 
questioned. Commercially prepared antisera must be 
exhaustively absorbed sequentially by a litany of 
Gram-negative organisms (Xu et al., 1984) to eliminate 
heterologous serological activity primarily because such
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sera are produced in animals immunized with whole cell 
vaccines which display a variety of serovar-specific and 
nonspecific antigens (Siebeling et al., 1984). The 
serovar or serotype-specific antigens Â, B, and C against 
which anti-01 sera are directed reside in the 
polysaccharide portion of the LPS of the outer membrane 
envelope (Redmond, 1975). While serovar-specific 
antisera prepared in rabbits immunized with V_^ cholerae 
polysaccharide-protein carrier conjugates (Adams and 
Siebeling, 1984; Chapter I, this dissertation) provide 
specificity for slide agglutination tests, it is 
monoclonal antibodies (MAbs) that probably will possess 
the specificity to detect individual V_j_ cholerae 01 cells 
in environmental samples. Monoclonal antibodies have 
been prepared against V_j_ cholerae 01 lipopolysaccharide 
(LPS) (Gustafsson and Holme, 1983; Gustafsson et al., 
1982). We have also prepared MAbs against the A, B, and 
C antigens of cholerae 01 LPS, and the intent of the 
study reported herein was to show that these MAbs are 
specific for V_̂  cholerae 01 LPS and that they show unique 
reactivity patterns when assessed by ELISA, slide 
agglutination, immunofluorescence, and immunoelectron 
microscopy. In addition, a defined mixture of MAbs may 
produce a superior serotyping reagent.
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MATERIALS AND METHODS
Bacterial strains. Table la lists the Vibrio 
cholerae 01 strains and cholerae non-01 serovars.
Table lb lists the heterologous Vibrio spp., and Table Ic 
identifies 37 bacterial genera and species utilized in 
this study to examine the specificity of the monoclonal 
reagents when tested by LPS ELISA, whole cell ELISA, 
slide agglutination, immunofluorescence, and 
immunoelectron microscopy.
LPS preparation, LPS, which contains antigen A, B, 
and C in cholerae 01 and the serovar-specif ic antigens 
of cholerae non-01, was extracted from selected V « 
cholerae strains by the phenol-water method of Westphal 
and Jann (1965). Vibrio cells, grown on trypticase soy 
agar (Difco Laboratories, Detroit, MI) in 10 to 12 Roux 
flasks for 24 h, were harvested in 0.15 M NaCl and washed 
two times prior to extraction.
Immunization protocol. Mice were primed with 
heat-killed whole cell vaccines prepared by the method of 
Sakasaki et al. ( 1970). V_j_ cholerae 01 Inaba (ATCC 
14033) and Ogawa (ATCC 14035) cells were harvested from a 
Kolle flask in 25 ml 0.15 M NaCl. The cell suspension 
was heated in a lOO'C water bath for 2 h, and then the
52
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Strain Serovar Strain Se rova r
No. Oecignaclon N o . Dealgnatlon
LA 5«75* 01 Inaba N-27 Id
CA 401 01 Inaba H-IO le
569# 01 Inaba F4 6D J
ATCC 14033 01 Inaba F50C K
LA 65N4 01 Inaba 639 1 L
LA 9214 01 Inaba 2002H M
SCN-7077 01 Inaba 2007H K
SCN-727 7 
N-999*
01 Inaba N-38 0
01 Inaba 2019H P
N-IOOO 01 Inaba 20I2H 0
N-lOOl 01 Inaba N-83 S
N-I002 01 Inaba 2008H T
N-I400 01 Inaba 2015H V
N-I40I 01 Inaba N-98 U
N-1402 01 Inaba 2016H X
N-1403 01 Inaba N-128 y
N-1404 01 Inaba 20I8H z
H-I405 01 Inaba 10F2A AA
N-1406 01 Inaba I0F31A 88
N-1407 01 Inaba 2009H CC
N-I408 01 Inaba 202 IH OD
N-I409 01 Inaba N-lOO FF
N-1410 01 Inaba N-69 CC
N-141 I 01 Inaba N-125 LL
S-14 1 2 01 Inaba N-87 MM
N-1413 01 Inaba N-46 NN
N-1416 01 Inaba N-94 00
N-1415 01 Inaba N-l 00
N-14 16 01 Inaba N-96 RR
N-1417 • 01 Inaba 2073 UU
N-14 ie‘ 01 Inaba Fla 45 XX
CA 411 01 Ogawa 2014H EEE
NIH 41 01 Ogawa VCE 25* CAL I
ATCC 14035 01 Ogawa VCE 27 CAL II
SCN-8122 01 Ogawa VCE 7 5 CAL III
SCN-8123 01 Ogawa
C
VCE 36 CAL IV
2026h ' #43*’ unk .
F8C D LA 6195 C/UU
FIA E LA 6169 0
H7C F LA 6480 FF
HlOA C LA 9217 unk.
F i e # H LA 9296 X/XX
N-37 la LA 9302 X/XX
M-149 Ic LA 9313 X/XX
See Table Ic for legenda.
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See Table Ic for legenda.
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Aclnetobacter calcoaceticus ATCC 19606'*
Agrobacterium tumefaciens unk.J
Aeromonaa hydrophile u n k .
Alcaligenes faecalis unk.
Arizona hinshawii unk.
Bacillus cereus u n k .
Bacillus megaterium u n k .
Bacillus sphaericus unk.
Bacillus subtilis un k .
Brucella abortus un k .
Citrobacter freundi unk.
Enterobacter aerogenes unk.
Enterobacter cloacae un k .
Escherichia coli ATCC 25922




Pleisiomonas shigelloides u n k .
Proteus morganii u n k .
Proteus vulgaris ATCC 13315
Pseudomonas aeruginosa ATCC 2003




Salmonella typhi u n k .
Salmonella typhimuriun unk.
Serratia marcescens ATCC 8100
Shigella flexneri u n k .
Shigella sonnei u n k .
Sporocarcina spp. unk.
Staphylococcus aureus ATCC 1 2598
Staphylococcus aureus u n k .
Staphylococcus epidermidis unk.
Streptococcus faecalis ATCC 19433
Yersinia en terocolitica u n k .
LA, Louisiana isolate.
^ ATCC, American Type Culture Collection isolate.
^ SON, Sea Grant Numerical designation.
^ N, Isolated by Nell Roberts, LA DHHR, Lake
Charles, LA.
^ H, Human isolates.
 ̂ LSU non-01 serovar designation.
^ VCE, Isolate obtained from WHO, Calcutta, India.




Isolated by Lynelle Ford, LA DHHR, Alexandria,
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
56
cells were sedimented at 3000 x g for 20 min and washed 
one time in saline. The cells were resuspended in saline 
to 116 units in a Klett-Summerson colorimeter at 660 nm. 
Female Balb/c mice 6-8 weeks of age were injected 
intraperitoneally with graded doses of the heat-killed 
vaccine every four to five days for one month. The mice 
were exsanguinated four days following the last 
immunization.
Fusion protocol. A modification of the method of Oi 
and Herzenberg (1980) was used to produce hybridomas, in
Q
which 1 X 10 immune spleen cells were mixed with 2.5 x 
10^ log phase SP2/0-Agl4 myeloma cells in 50% 
polyethylene glycol 3000-3700 (ATCC, Rockville, MD). The 
fusion mixture was suspended at a concentration of 7.5 x 
10^ cells/ml in bicarbonate buffered RPMI 1640 (CISCO, 
Grand Island, NY), supplemented with 15% fetal bovine 
serum (CISCO), 2 mM L-glutamine (Sigma Chemical Co., St. 
Louis, MO), 1% MEM non-essential amino acids (Hazleton 
Research Products, Inc., Denver PA), 10 units/ml 
penicillin, and 10 ug/ml streptomycin, and distributed to 
each well of a 96 well tissue culture plate which had 
been seeded 24 h earlier with a thymocyte feeder layer. 
The plates were incubated at 37*C in an atmosphere of 
7.5% COg in air. Hybrid cells were selected by 
utilization of the HAT selection system developed by
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Littlefield (1964), and hybridoma supernatant fluids were 
tested for antibody activity by ELISA. Hybridomas of 
interest were cloned by three successive limiting 
dilutions #
Production of MAbs. Selected hybridomas, which 
secreted LPS-specific MAbs, were grown in 500 ml bottles 
which contained 200 ml medium at 37*C in an atmosphere 
of 7.5% COg in air for 1 week. Monoclonal antibodies of 
the IgG isotype were purified from culture fluid on a 
Protein A-Sepharose CL-4B column (Pharmacia Biotechnology 
Products, Piscataway, NJ), and IgM MAbs were concentrated 
from supernatant fluids by precipitation in saturated 
(NH^)2S0^ (Schreier et al., 1980).
Immunoglobulin isotyping. Each MAb was isotyped by 
ELISA using the HyClone Sub-Isotyping Kit (HyClone 
Laboratories, Salt Lake City, UT).
LPS ELISA. The enzyme linked immunosorbent assay 
protocol used to identify MAb activity specific for V. 
cholerae 01 LPS was modified from the procedures 
described by Schreier et al. (1980) and Voiler et al. 
(1976). Each well of a 96 well flat bottomed polyvinyl 
chloride (PVC) microtiter plate (Dynatech Laboratories, 
Alexandria, VA) was coated with 50 ul of LPS solution (50
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ug/ml) in phosphate buffered saline (8.0 g/L NaCl, 0.2 
g/L KHgPO^, 1.2 g/L NagPO^, 0.2 g/L KOI, 0.2 g/L N a N ^ , pH 
7.2) (PBS-Az). The plates were incubated, uncovered, 
overnight at 37*0. After washing each well one time 
with PBS-Az, uncoated sites in each well were blocked by 
the addition of 200 ul of 2% bovine serum albumin (BSA) 
(Sigma) in PBS-Az. The covered culture plates were 
floated in a 37*0 water bath for 2 h, and then each 
well was washed one time with PBS-Az. Next, 50 ul of 
hybridoma culture supernatant fluid was added to each 
well, and the plates were floated in a 37*0 water bath 
for 1 h. Each well was washed four times with PBS-Az, 
and then 50 ul of goat anti-mouse Ig (IgG, IgM, and IgA) 
conjugated with alkaline phosphatase (Kirkegaard and 
Perry Laboratories, Gaithersberg, MD) were added to each 
well. The covered plate was floated in a water bath at 
37*0 for 1 h. Each well was then washed five times 
with PBS-Az, and 200 ul p-nitrophenyl phosphate (1 mg/ml) 
(Sigma 104 Phosphatase Substrate, Sigma) in 
diethanolamine buffer (97 ml diethanoloamine, 0.2 g/L 
NaNg, 0.1 g/L MgOlg'bHgO, pH 9.8) was added to each well. 
The plate was incubated, in the dark, at 37*0 for 30 
min. The enzyme-substrate reaction was stopped by the 
addition of 25 ul 3 N NaOH to each well. The absorbance, 
at 405 nm, for each well was read and recorded by an EIA 
Reader (Bio-Tek Instruments, Inc.). An absorbance
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reading of 0.200 or greater, which can be discerned 
visually, was considered positive. The fluid in negative 
control wells gave absorbance readings of less than 
0 .100.
Whole cell ELISA. Each well of an Immulon II 
microtiter plate (Dynatech) was coated with whole cell 
antigens. Each test organism was grown on trypticase soy 
agar slants at 37"C for 18 to 24 h . The cells were 
harvested and suspended in PBS-Az at a concentration of 6 
X 10  ̂ cells/ml. Fifty ul of the suspension was added to 
each well, and the plates were incubated, uncovered, at 
37*C overnight to dehydrate the cell suspension 
(coating procedure). All subsequent steps in the ELISA 
protocol were carried out as described above.
Slide agglutination. Each bacterial isolate tested 
by slide agglutination was harvested in PBS from an 18 to 
24 h trypticase soy agar slant culture. One drop of each 
cell suspension was mixed with various dilutions of each 
MAb preparation on a glass surface and examined over a 1 
min period for evidence of agglutination.
Immunofluorescence. Selected MAbs were conjugated 
with fluorescein isothiocyanate (FITC) (Sigma) by the 
method of Coding (1983). MAbs, fractionated from culture
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fluids, were dialyzed overnight against 
carbonate/bicarbonate buffer (8.6 g/L NagCOg, 17.2 g/L 
NaHCOg, pH 9.5), and the protein concentration of the MAb 
Ig was estimated by reading the optical density of the 
MAb solution at 280 nm. Fluorescein isothiocyanate was 
dissolved in dimethyl sulfoxide (1 mg/ml) and added to 
the MAb solution, dropwise while stirring, until a ratio 
of 100 ug fluorochrome : 1 mg MAb protein was reached.
The conjugation reaction was allowed to proceed for 3 h 
in the dark at room temperature. The unreacted FITC was 
separated from the MAb-FITC conjugate by gel filtration 
on a Sephadex G-25 column equilibrated with PBS-Az. The 
conjugate was stored at A*C in the dark.
Bacterial strains to be examined by 
immunofluorescence were harvested in PBS and adjusted to 
3 X 10  ̂ cells/ml. A loopful of each cell suspension was 
spread on a glass slide. The dry smears were fixed in 
95% ethanol, heat-fixed at 55'C for 10 min, and stored 
at -70*0.
Prior to staining, each slide was thawed and rinsed 
one time in PBS. Each smear was stained with a 
BSA-rhodamine isothiocyanate conjugate (Difco) (diluted 
1:4 in PBS-Az) and incubated at 37*0 in a humidity 
chamber for 30 min. The slides were rinsed and immersed 
in PBS for 10 min. Next, each smear was covered with the 
MAb-FITC conjugate and incubated at 37*C in a humidity
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chamber for 30 min. The slides were washed as above and 
mounted with buffered glycerol saline (Cherry, 1974) and 
a coverslip. The slides were examined with an Ortholux 
II epifluorescence microscope (Ernst Leitz, Wetzlar, W. 
Germany).
Immunoelectron microscopy. A parlodion and carbon 
coated copper grid was floated, for 15 min at room 
temperature, on 25 ul of a bacterial suspension (9 x 10^ 
cells/ml in PBS). The grid was drained onto tissue paper 
and floated on 25 ul of 2% BSA in PBS-Az for 15 min to 
reduce non-specific binding by the support film. The 
grid was then drained and placed on 25 ul of MAb solution 
for 30 min at room temperature. The grid was washed by 
floating it, sequentially, on three drops of PBS for 3 
min each. Next, the grid was placed on 25 ul of 
anti-mouse Ig (IgG and IgM) conjugated with 15 nm 
colloidal gold particles (Ted Pella, Inc., Tustin, CA) 
and incubated at room temperature for 30 min. The grid 
was washed three times with PBS, and two times on drops 
of deionized water for 2 to 3 sec each. In some 
instances, the cells were stained with 2% phosphotungstic 
acid (pH 7) (negative stain) for 10-15 sec. Each 
specimen was examined on a JEOL lOOCX electron microscope 
at 80 kV.
Ultrathin sections of cholerae 01 were prepared
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by fixing the cells In 2% glutaraldehyde in 0.1 M 
cacodylate buffer (pH 7) for 20 min at room temperature. 
The cells were washed with the buffer and fixed with 2% 
osmium tetroxide in 0.05 M cacodylate buffer for 1 h. 
Next, the cells were suspended in 1% agarose, minced into
3mm blocks, and treated with 1% uranyl acetate for 1 h in 
the dark at room temperature. The preparation was 
dehydrated in ascending concentrations of ethanol, and 
then infiltrated and embedded in LR White acrylic resin 
(E.F. Fullam, Inc., Latham, NY) overnight. The 
polymerization temperature was 60*C. Sections were cut 
on a DuPont MT 5000 Sorvall Ultra Microtome, mounted on 
parlodion and carbon coated grids, and indirectly labeled 
with colloidal gold particles by the procedure described 
for whole cell mounts.
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RESULTS
Monoclonal antibodies secreted by hybridomas 
prepared from spleen cells of mice immunized with V . 
cholerae 01 whole cell vaccines were assessed first for 
their serological reactivity and specificity for 01 
LPS-associated antigens (Table 2). Culture fluid from 
hybridoma clones A 6 , A12, and A19 reacted with LPS of 
both Inaba and Ogawa serovars in the ELISA assay and were 
directed against the A antigen. Clone AlO and All 
culture fluid reacted with Ogawa LPS only (antigen B), 
whereas MAbs secreted by A18 reacted with Inaba LPS but 
not Ogawa LPS (C antigen). Each MAb was also tested 
against LPS extracted from 9 non-Ol cholerae serovars, 
and, except for MAbs produced by clone A19, which were 
weakly positive with LPS extracted from serovars Q and Y, 
the other five MAbs were negative.
Different reactivity patterns were observed for each 
of the three anti-A clones (A6, A12, and A19) when tested 
against 01 LPS preparations. Culture fluid from A6 
reacted strongly with all 01 LPS preparations except V . 
cholerae Inaba CA 401 LPS. Monoclonal antibodies from 
clone A12 reacted more strongly with Ogawa LPS than Inaba 
LPS, and did not react at all with LPS extracted from V . 
cholerae Inaba CA 401 or 569B. Clone A19 produced 
intense reactions with each of the seven 01 LPS 
preparations.
63
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Table 2. Serological reactivity and specificity of
monoclonal antibodies for Vibrio cholerae 01 
LPS-associated antigens.
ELISA. reaction* for MAbs from clones :
LPS extracted 
from : A6 A12 A19 AlO All A18
Inaba
LA 5875 +++ + +++ 0 0 ++
ATCC 14033 +++ + +++ 0 0 ++
CA 401 0 0 +++ 0 0 ++
569B ^ ++ 0 +++ 0 0 ++
unk. Inaba +++ + +++ 0 0 ++
Ogawa
CA 411 +++ +++ ++ ++ ++ 0
NIH 41 +++ +++ ++ ++ ++ 0
Non-Ol
0 0 0 0 0 0
K 0 0 0 0 0 0
0 0 0 0 0 0 0
Q 0 0 + 0 0 0
X 0 0 0 0 0 0
Y 0 0 + 0 0 0
FF 0 0 0 0 0 0
UU 0 0 0 0 0 0
XX 0 0 0 0 0 0
+++, *4 0 5^1"°'
++, *405=0 -5-1 ' 0
+ . *4 05=0 '2-0 ' 5
0 . *405^0 -1-
V . cholerae 01 of unknown pedigree.
See Table 1 for V. cholerae non-Ol serovar
designation.
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The serological specificity of each MAb was examined 
next in the whole cell ELISA procedure (Fig. 1). 
Supernatant fluid from each clone was tested against each 
of the 145 bacterial isolates listed in Table l a , lb, and 
Ic. Monoclonal antibodies from clones A6 and A12 reacted 
with each cholerae 01 whole cell preparation, and, as 
observed previously, MAbs secreted by clone A12 reacted 
more strongly with the Ogawa serovars than with Inaba 
serovars. Each anti-A MAb, except that produced by clone 
A19, reacted with the two Staphylococcus aureus isolates 
tested. Since the MAbs are of the IgG3 isotype, the 
reaction observed was due, presumably, to binding of the 
Fc portion of the Ig to the protein A cell wall component 
of aureus. Monoclonal antibodies from clone A19 
displayed intermediate reactions with cholerae 01 and 
also produced low level reactions with cholerae non-Ol 
serovars C, E, Y, Z, and BB, and with Serratia 
marcescens. Monoclonal antibodies from clone A19 was 
isotyped as IgM and did not react with the Sjj_ aureus 
isolates. Monoclonal antibodies secreted by clones AlO 
and All recognized the Ogawa strains tested and gave 
negative results with all other isolates tested.
The serological specificity of each of the three 
anti-A MAbs was evaluated next by slide agglutination 
(Table 3). Clones A6 and A12 secreted MAbs which 
agglutinated each cholerae 01 serovar only. None of 
the twelve non-Ol serovars, four heterologous Vibrio
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Figure 1. Specificity of monoclonal antibodies 
secreted by clones A 6 , A12, A19, AlO, 
and All when assessed by whole cell 
ELISA vs the organisms listed in tables 
la, lb, and Ic. Values are the mean for 
each category.
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Table 3. Slide agglutination reactions of monoclonal 
antibodies tested against homologous and 
heterologous whole cells.
Slide agglutination reaction® of MAbs:
Live 




14033 ++ ++ + +++
CA411 ++ ++ + +++
CA 401 ++ ++ + +++
LA5875 ++ ++ + +++
14035 ++ ++ + +++
NIH41 ++ ++ + +++
569B ++ ++ + +++
N-999 ++ ++ + +++
N-1405 ++ ++ + +++
N-1414 ++ ++ + +++
LA9214 ++ ++ + +++
LA8584 ++ ++ + +++
V. cholerae non-Ol^
C 0 0 0 0
E 0 0 0 0
M 0 0 0 0
Q 0 0 0 0
X 0 0 0 0
Y 0 0 0 0
Z 0 0 0 0
BB 0 0 0 0
GO 0 0 0 0
FF 0 0 0 0
LL 0 0 0 0
XX 0 0 0 0
® +++, Agglutination in 1:25 dilution of MAb at 1 min;
++, agglutination in 1:5 dilution of MAb at 1 min;
+, agglutination in undilute MAb at 1 min.
^ Documented ATCC and laboratory strains of the Ogawa
and Inaba serovars; See Table la.
^ V. cholerae non- 01 serological varieties ; See Table
la.
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spp., or four heterologous genera tested agglutinated*
The optimal agglutination titer for each MAb could be 
increased 5-fold when they were mixed in equal parts, 
with no resultant loss in specificity* Monoclonal 
antibodies secreted by A19 agglutinated 01 V^_ cholerae 
and ^  marcescens cells weakly, but did not agglutinate 
whole cell suspensions of the non-Ol serovars Q and Y*
The serological activity for each of the three 
anti-A MAbs was assessed next by immunofluorescence* 
Monoclonal antibodies produced by clones A 6 , A12, and A19 
were each conjugated with FITC and the fluorescence 
intensity examined by the direct assay (Table 4)* The A6 
MAb-FITC conjugate exhibited moderate fluorescence with 
both Inaba and Ogawa 01 cells, which displayed a diffuse 
apple-green stain quality* The A12 MAb-FITC conjugate 
exhibited brilliant fluorescence with Ogawa cells, and 
clearly showed red cells outlined brightly with green 
FITC (Fig* 4), while Inaba cells displayed marginal 
fluorescence (Fig* 3)* In contrast, the A19 MAb-FITC 
conjugate displayed good FA activity with Inaba cells but 
produced poor fluorescence with Ogawa cells* A mixture 
of the three FITC-tagged MAbs improved the overall 
intensity and produced 3+ reactions with Inaba cells and 
4+ reactions with Ogawa cells* A mixture of A6 and A12 
did not improve the staining intensity with Inaba cells, 
but the specificity of the reagent for 01 cholerae was 
preserved *
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Table 4. Immunofluorescence Intensity of anti-A 
monoclonal antibodies.
FA reactivity of MAb-FITC vs whole cells of:
V. cholerae heterologous
MAb secreted 
by clone*: Inaba Ogawa N on—01 Vibrio spp. genera
A6 2+ 2+ 0 0 0
A12 2+ 4+ 0 0 0
A19 3 + 1 + n.d. n.d. n.d.
mix of 
A6 and A12 2+ 4+ 0 0 0
mix of A 6 , 
A12, and A19 3+ 4+ n.d. n.d. n.d.
^ anti-A secreting clones.
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Examples of immunofluorescence obtained with 
MAb-FITC conjugates.
Figure 2. cholerae non-Ol serovar P (2019H)
stained with RITC-BSA and A12 MAb-FITC : 0,
Figure 3. V_̂  cholerae 01 Inaba LA 5875 stained
with RITC-BSA and A12 MAb-FITC : 2+.
Figure 4. V_j_ cholerae 01 Ogawa CA 411 stained 
with RITC-BSA and A12 MAb-FITC ; 4+.
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The unique reactivity patterns that each anti-A MAb 
displayed by ELISA and FA were also visualized by 
indirect immunoelectron microscopy. Vibrio cholerae 01 
cells were stained with MAbs from clones A 6 , A12, and A19 
and then labeled with anti-mouse Ig (IgG and IgM) 
conjugated with colloidal gold. Inaba (Fig. 5) and Ogawa 
(Fig. 9) cells treated with anti-mouse Ig-colloidal gold 
in the absence of MAb showed virtually no staining.
Inaba cells stained well with MAbs secreted by clone A6 
(Fig. 6), marginally by those from clone A12 (Fig. 7), 
and very strongly by MAbs from clone A19 (Fig. 8). 
Monoclonal antibodies from clone A6 also reacted with 
Ogawa cells (Fig. 10), A12 MAbs bound Ogawa cells (Fig.
11) more strongly than Inaba cells, and A19 MAbs bound 
Ogawa cells very well (Fig. 12).
A mixture of MAbs, from clones A 6 , A12, and A19, 
were used to stain both whole cells and thin sections of 
V. cholerae 01. The mixture reacted strongly with both 
Inaba and Ogawa whole cells (Figs. 13 and 15), while thin 
sections were labeled less dramatically (Figs. 14 and 
16). The mixture reacted with thin sections to a greater 
extent than when MAbs were used individually (figures not 
shown).
Finally, the specificity of the anti-B and anti-C 
MAbs was examined by immunoelectron microscopy. Anti-B 
MAbs bound to Ogawa cells strongly in both the whole 
mount (Fig. 17) and the thin section (Fig. 19) and did
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Immunoelectron microscopy of Inaba cells stained 
with anti-A MAbs and anti-mouse Ig-colloldal gold 
conjugate.
Figure 5. cholerae 01 LA 5875 treated with
anti-mouse Ig-colloldal gold conjugate In 
the absence of MAb.
Magnlflcatlon=30,000.
Figure 6. cholerae 01 LA 5875 stained with
MAbs secreted by clone A6. 
Magnification®29,000.
Figure 7. cholerae 01 LA 5875 stained with
MAbs secreted by clone A12.
Magnlflcatlon=28,500.
Figure 8. V_̂  cholerae 01 ATCC 14033 stained
with MAbs secreted by clone A19. 
Magnlflcatlon=28,500.
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Immunoelectron microscopy of Ogawa cells stained 
with anti-A MAbs and anti-mouse Ig-colloidal gold 
conjugate.
Figure 9. cholerae 01 CA 411 treated with
anti-mouse Ig-colloidal gold conjugate in 
the absence of MAb.
Magnification*33,000.
Figure 10. cholerae 01 CA All stained with
MAbs secreted by clone A6 . 
Magnification*28,500.
Figure 11. V_̂  cholerae 01 CA 411 stained with
MAbs secreted by clone A12.
Magnification=42,000.
Figure 12. cholerae 01 CA 411 stained with
MAbs secreted by clone A19.
Magnification=39,000.
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Immunoelectron microscopy of cholerae 01 stained 
with a mixture of anti-A MAbs (A6, A12, and AI9) and 
anti-mouse Ig-colloidal gold conjugate.
Figure 13. V_̂  cholerae 01 Inaba ATCC 14033,
Magnification®35,000.
Figure 14. Thin section of cholerae 01 
Inaba ATCC 14033.
Magnification®20,000.
Figure 15. V_j_ cholerae 01 Ogawa CA 411. 
Magnification®19,500.
Figure 16. Thin section of V_j_ cholerae 01 
Ogawa CA 411.
Magnification®24,500.
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Immunoelectron microscopy of V . cholerae 01 stained 
with MAbs secreted by clone All (anti-B) and anti-mouse 
Ig-colloidal gold conjugate.
Figure 17. cholerae 01 Ogawa CA 411.
Magnification®44,500.
Figure 18. cholerae 01 Inaba LA 5875.
Magnification=19,000.
Figure 19. Thin section of cholerae 01 
CA 411.
Magniffaction®35,000.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
81
-m
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
82
not react with Inaba cells (Fig. 18). In a reciprocal 
manner, the anti-C MAbs, secreted by clone A18, reacted 
with both Inaba whole mounts (Fig 20) and thin sections 
(Fig. 22) but did not bind to Ogawa cells (Fig. 21).
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Immunoelectron microscopy of cholerae 01 stained 
with MAbs secreted by clone A18 (anti-C) and anti-mouse 
Ig-colloidal gold conjugate.
Figure 20. cholerae 01 Inaba ATCC 14033
Magnification=31,000.
Figure 21. cholerae 01 Ogawa CA 411.
Magnification*25,500.
Figure 22. Thin section of cholerae 01 
CA 411.
Magnification*32,500.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
84
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
DISCUSSION
Bacterial agglutination was first demonstrated by 
Gruber and Durham In 1896 with cholera vibrios. This 
serological reaction was quickly adopted and used to 
Identify enteric pathogens (Achard and Bensuade, 1896) 
and Is still relied upon today to confirm the isolation 
of Vibrio cholerae 01. Each of the Vibrio species 
possesses unique flagellar (H) antigens (Gardner and 
Venkatraman, 1935), and antl-H serum has been used to 
Identify environmental and clinical V_m_ cholerae isolates 
(Tassln et al., 1982; Simonson and Slebellng, 1986). 
Vibrio cholerae Is subdivided serologically Into 
serotypes or serovars based on the diversity of 
polysaccharide (PS)-assoclated 0 antigens expressed In 
the cell wall. Currently, typing sera are produced In 
rabbits Immunized with either live (Smith, 1979) or 
heat-killed (Sakasakl and Shimada, 1973) whole cell 
vaccines. These undefined Immunogens, however, often 
Induce non-specific serological activities directed 
against antigens other than PS In the bacterial cell 
coat. Efforts to Improve the specificity of antisera for 
PS antigens exclusively were successful when typing sera 
were produced In rabbits Immunized with purified PS 
conjugated with a protein carrier (Adams and Slebellng, 
1984; Chapter I, this dissertation). Antiserum, however.
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
86
is by nature an undefined reagent and is being replaced 
by monoclonal antibodies produced by hybridoma 
technology.
Monoclonal antibodies directed against V_j_ cholerae 
01 LPS were prepared and evaluated serologically against 
a variety of homologous and heterologous organisms. The 
MAbs displayed specificity for V. cholerae 01. Clones 
A 6 , A12, and A19 secreted MAbs which reacted with both 
Inaba and Ogawa serovars (A antigen), AID and All reacted 
with Ogawa serovars only (B antigen), and A18 reacted 
solely with Inaba serovars (C antigen). Clone A19 MAbs 
(anti-A) reacted with five cholerae non-01 serovars 
and Serratia marcescens. Monoclonal antibodies which 
react with various members of the Enterobacteriaceae, 
Pseudomonaceae, and Vibrionaceae have been reported, but, 
in each instance the antibody activity was directed 
against sites in the core region or lipid A (Matharia et 
al., 1984; Perez-Perez et al., 1986; Peters et al., 1985; 
Sciortino et al., 1985). If A19 activity was directed 
against the lipid A or core region, it should have 
reacted with each of the non-01 cholerae serovars 
tested in the LPS ELISA procedure; A19 MAbs, however, 
reacted only with non-01 serovars Q and Y. The 
serological similarities between these two non-01 
serovars were discussed previously (Siebeling et al., 
1984). We did not possess LPS preparations from serovars
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C, E, Z, and BB or ^  marcescens at the time these 
reactions were discovered in the whole cell ELISA. It is 
possible that Â19 reacts with a non-LPS associated 
antigen on these organisms. Monoclonal antibodies 
secreted by clone A19 recognize an epitope shared across 
serovar boundaries and may prove useful when the 
serological relatedness of the various serovars of V « 
cholerae are examined.
Monoclonal antibodies secreted by clones A 6 , AI2, 
and A19 each displayed unique reactivity patterns when 
tested against cholerae 01 by LPS and whole cell 
ELISA, immunofluorescence, and immunoelectron microscopy. 
These findings suggest that each MAb recognizes distinct 
epitopes on the A antigen, although epitope mapping was 
not done in this study to support this conclusion. In an 
effort to increase the sensitivity of the slide 
agglutination serotyping reagent, the three anti-A MAbs 
were mixed and evaluated. A 12-fold increase in slide 
agglutination titer resulted when MAbs from clones A 6 ,
A12, and A19 were mixed; in addition, an increase in gold 
labeling and fluorescence intensity was observed when 
this mixture was tested. Unfortunately, this mixture 
agglutinated ^  marcescens cells at this dilution. When 
A19 was omitted, the mixture of A6 and A12 increased the 
optimal slide agglutination titer 5-fold over that of 
each MAb used alone, and serological specificity for
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cholerae 01 was retained. A mixture of MAbs, each 
specific for distinct determinants on a defined 
serovar-specific antigen, may create a serological 
reagent which possesses the advantages of the monoclonal 
antibodies (infinite supplies of a single specificity) 
and the polyvalent antisera (broader spectrum of 
reactivities yielding sharp, visible reactions).
Immunoelectron microscopy studies revealed that each 
MAb reacted with the sheath of the polar flagellum 
possessed by cholerae 01 (Figs. 6, 7, 8, 13, 15, 17, 
and 20). This finding supports the data reported by 
Castellani-Pastoris et al. (1980) that the flagellar 
sheath is contiguous with the cell wall and possesses LPS 
antigens.
Serovar-specific MAbs may be useful to monitor the 
environment for the presence of 01 V . cholerae. Vibrio 
cholerae 01 serovars were detected by indirect 
immunofluorescence (Xu et al., 1984) in environmental 
samples that did not yield these organisms by 
conventional bacteriological methods, and it was 
postulated that Vji_ cholerae 01 are autochthonous members 
of the environment present in a non-recoverable state 
(Colwell et al., 1985). Kaper et al., (1981) reported 
that 01 cholerae isolated from the environment in the 
absence of disease were non-toxigenic. These isolates 
lacked the structural genes which encode for the cholera
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toxin, and hence could not serve as the reservoir for the 
cholera-causing 01 organisms. Goldberg and Murphy (1983) 
have recently discovered a vibriophage, VcA3, which can 
incorporate randomly into the genome of cholerae. 
However, VcA3 integrated at the same site in each 
environmental or clinical cholerae 01 isolated from 
the Gulf Coast area, regardless of whether they were Tox* 
or Tox” . This finding suggests that there is a clonal 
relationship among the toxigenic and non-toxigenic Gulf 
Coast Vĵ  cholerae 01 strains and that there must be some 
mechanism for the addition or deletion of the cholera 
toxin genes.
The ecological niche for V_̂  cholerae 01 is an 
intriguing mystery, but the dilemma may be answered by 
analysis of environmental samples using defined 
serological reagents, such as serovar-specific MAbs, 
coupled with an isolation event and toxin studies.
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